Edgewell Personal Care (EPC) 10-Q4 May 172017 Q2 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Mar. 31, 2017	Apr. 30, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	EDGEWELL PERSONAL CARE COMPANY
Entity Central Index Key	1,096,752
Current Fiscal Year End Date	--09-30
Entity Filer Category	Large Accelerated Filer
Trading Symbol	EPC
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q2
Amendment Flag	false
Entity Common Stock, Shares Outstanding		57,421,222

Condensed Consolidated Statemen

Condensed Consolidated Statements of Earnings and Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Net sales	$ 611	$ 611.2	$ 1,096	$ 1,106.3
Cost of products sold	301.4	300.1	558.4	567.7
Gross profit	309.6	311.1	537.6	538.6
Selling, general and administrative expense	103.9	99.7	197.7	200.1
Advertising and sales promotion expense	82.5	85	133.1	131.6
Research and development expense	17.5	16.7	33.8	32.7
Restructuring charges	5.5	5	12.4	23.5
Industrial sale charges	0	0.2	0	0.2
Interest expense associated with debt	17.3	17.8	34.7	35.5
Other income, net	(6.6)	(4.6)	(8.5)	(7)
Earnings before income taxes	89.5	91.3	134.4	122
Income tax provision	23.8	25.2	35.2	32.2
Net earnings	$ 65.7	$ 66.1	$ 99.2	$ 89.8
Basic net earnings per share (in usd per share)	$ 1.14	$ 1.11	$ 1.72	$ 1.51
Diluted net earnings per share (in usd per share)	$ 1.14	$ 1.10	$ 1.72	$ 1.49
Condensed Consolidated Statements of Comprehensive Income
Net earnings	$ 65.7	$ 66.1	$ 99.2	$ 89.8
Other comprehensive income (loss), net of tax
Foreign currency translation adjustments	10	17.8	(28.7)	7.3
Pension and postretirement activity, net of tax	0.6	(6.5)	4.5	(6)
Deferred (loss) gain on hedging activity, net of tax	(3.4)	(4.3)	4.5	(6.2)
Total other comprehensive income (loss), net of tax	7.2	7	(19.7)	(4.9)
Total comprehensive income	$ 72.9	$ 73.1	$ 79.5	$ 84.9

Condensed Consolidated Stateme3

Condensed Consolidated Statements of Earnings and Comprehensive Income (Parenthetical) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Pension and postretirement activity, tax	$ 0.5	$ 0.3	$ 1.1	$ 0.7
Deferred (loss) gain on hedging activity, tax	$ 1.8	$ 2	$ (2.3)	$ 2.9

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2017	Sep. 30, 2016
Current assets
Cash and cash equivalents	$ 402.9	$ 738.9
Trade receivables, less allowance for doubtful accounts	311	260.7
Inventories	366.4	309.2
Other current assets	142.8	143.2
Total current assets	1,223.1	1,452
Property, plant and equipment, net	462	486.1
Goodwill	1,426.6	1,420.3
Other intangible assets, net	1,391.2	1,385.1
Other assets	27.7	28
Total assets	4,530.6	4,771.5
Current liabilities
Current maturities of long-term debt	0	281.8
Notes payable	19.7	18.5
Accounts payable	231.6	196.5
Other current liabilities	306.1	371.4
Total current liabilities	557.4	868.2
Long-term debt	1,609.8	1,544.2
Deferred income tax liabilities	251.7	255.3
Other liabilities	262.2	274.8
Total liabilities	2,681.1	2,942.5
Shareholders' equity
Preferred shares	0	0
Common shares	0.7	0.7
Additional paid-in capital	1,620.2	1,642.5
Retained earnings	1,046.4	946
Common shares in treasury at cost	(600.9)	(563)
Accumulated other comprehensive loss	(216.9)	(197.2)
Total shareholders' equity	1,849.5	1,829
Total liabilities and shareholders' equity	$ 4,530.6	$ 4,771.5

Condensed Consolidated Balance5

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2017	Sep. 30, 2016
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 7.6	$ 4.9
Preferred shares, par value (in usd per share)	$ 0.01	$ 0.01
Preferred shares, authorized (in shares)	10,000,000	10,000,000
Preferred shares, issued (in shares)	0	0
Preferred shares, outstanding (in shares)	0	0
Common shares, par value (in usd per share)	$ 0.01	$ 0.01
Common shares, authorized (in shares)	300,000,000	300,000,000
Common shares, issued (in shares)	65,251,989	65,251,989
Common shares, outstanding (in shares)	57,421,222	57,914,448
Treasury shares (in shares)	7,830,767	7,337,541

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flow from Operating Activities
Net earnings	$ 99.2	$ 89.8
Non-cash restructuring costs	2.8	1.2
Depreciation and amortization	46.9	44.6
Deferred compensation payments	(25.7)	(7)
Share-based compensation expense	11.4	13.1
International pension funding	0	(100.5)
Other, net	(11.1)	(10.2)
Changes in current assets and liabilities used in operations	(123.9)	(103.6)
Net cash used by operating activities	(0.4)	(72.6)
Cash Flow from Investing Activities
Capital expenditures	(30.4)	(34.5)
Acquisitions, net of cash acquired	(34)	0
Proceeds from sale of assets	5.9	0
Net cash used by investing activities	(58.5)	(34.5)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	181	395.3
Cash payments on debt with original maturities greater than 90 days	(393)	(261)
Net increase (decrease) in debt with original maturities of 90 days or less	1.2	(5.6)
Common shares purchased	(58.5)	(78.9)
Other, net	2	0
Net cash (used by) from financing activities	(267.3)	49.8
Effect of exchange rate changes on cash	(9.8)	5.7
Net decrease in cash and cash equivalents	(336)	(51.6)
Cash and cash equivalents, beginning of period	738.9	712.1
Cash and cash equivalents, end of period	$ 402.9	$ 660.5

Background and Basis of Present

Background and Basis of Presentation	6 Months Ended
Background and Basis of Presentation	Mar. 31, 2017
Background and Basis of Presentation [Abstract]
Background and Basis of Presentation	Background and Basis of Presentation Background Edgewell Personal Care Company, and its subsidiaries (collectively, "Edgewell" or the "Company"), is one of the world's largest manufacturers and marketers of personal care products in the wet shave, sun and skin care, feminine care and infant care categories. Edgewell has a portfolio of over 25 brands and a global footprint in more than 50 countries. The Company conducts its business in the following four segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products and Bulldog® men's skin care products, as well as Wet Ones® wipes and Playtex® household gloves. • Feminine Care includes tampons, pads and liners sold under the Playtex® Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand. • All Other includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems. Basis of Presentation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its controlled subsidiaries and have been prepared in accordance with United States ("U.S.") generally accepted accounting principles ("GAAP"), under the rules and regulations of the U.S. Securities and Exchange Commission (the "SEC"). The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenues and expenses. Actual results may differ materially from those estimates. All intercompany balances and transactions have been eliminated in consolidation and, in the opinion of management, all normal recurring adjustments considered necessary for a fair presentation have been included in the interim results reported. The fiscal year-end balance sheet data was derived from audited consolidated financial statements, but do not include all of the annual disclosures required by GAAP; accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited annual consolidated financial statements included in its Annual Report on Form 10-K filed with the SEC on November 18, 2016. Acquisition of Bulldog Skincare. On October 31, 2016, the Company completed the acquisition of Bulldog Skincare Holdings Limited ("Bulldog"), a men's grooming and skincare products company based in the United Kingdom ("U.K."). The results of Bulldog for the post-acquisition period are included within the Company's results for the three and six months ended March 31, 2017. For more information on the acquisition, see Note 2 of Notes to Condensed Consolidated Financial Statements. Recently Issued Accounting Pronouncements. In November 2016, the Financial Accounting Standards Board ("FASB") issued an Accounting Standards Update ("ASU") which requires that the statement of cash flows explain the change during the period in the total of cash, cash equivalents and amounts generally described as restricted cash or restricted cash equivalents. These amounts should be included within cash and cash equivalents when reconciling the beginning and ending balances for the periods shown on the statement of cash flows. The ASU requires retrospective application, and will be effective for the Company beginning October 1, 2018, with early adoption permitted. The Company does not expect to early adopt this guidance and the impact on the financial statements is not expected to be material. In January 2017, FASB issued new guidance clarifying the definition of a business, reducing the number of transactions that need to be further evaluated and providing a framework to assist entities in evaluating whether both an input and a substantive process are present. The amendments in the ASU specify that when the fair value of the gross assets acquired or disposed of is concentrated in a single identifiable asset or a group of similar identifiable assets, the integrated set of assets and activities is not a business. The guidance also requires that an integrated set of assets and activities must include, at a minimum, an input and a substantive process that together significantly contribute to the ability to create output to be considered a business, and removes the evaluation of whether a market participant could replace the missing elements. The ASU will be effective for transactions occurring after October 1, 2018, with early adoption permitted. In January 2017, FASB issued new guidance which simplifies the subsequent measurement of goodwill by eliminating step 2 from the goodwill impairment test. Under existing guidance, an entity performs procedures to determine the fair value at the impairment testing date of its assets and liabilities following the same procedures required when determining the fair value of assets acquired and liabilities assumed in a business combination. The amended guidance requires an entity to perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, and recognize an impairment charge to the extent the carrying amount exceeds the fair value and does not exceed the total amount of goodwill allocated to the reporting unit. The ASU will be effective for the Company beginning October 1, 2021, with early adoption permitted, and should be applied prospectively. The Company is in the process of determining what impact, if any, the new guidance will have on its annual impairment testing and if it will early adopt the new guidance. In March 2017, FASB issued new guidance to improve the presentation of net periodic pension and postretirement benefit cost. Under existing guidance, the components of net periodic pension and postretirement benefit cost are aggregated and reported in the same line item as other compensation costs arising from services rendered by the applicable employees during the period. The amendments change these requirements so that only the service cost component is recorded in the same line item as other compensation costs for the applicable employees, and all other components of net periodic pension and postretirement benefit cost are recorded on a separate line item outside of income from operations. The amendments also specify that only the service cost component is eligible for capitalization. The ASU will be effective for the Company beginning October 1, 2018, with early adoption permitted October 1, 2017, and will be applied retrospectively for the presentation of the cost components and prospectively for the capitalization of the service cost component. The Company expects that the retrospective impact of adoption on its Consolidated Statement of Operations for the year ended September 30, 2016 will be an increase in Cost of products sold, Selling, general and administrative expense and Other income, net of $3.3 , $1.2 and $4.5 , respectively.

Acquisition

Acquisition	6 Months Ended
Acquisition	Mar. 31, 2017
Acquisition [Abstract]
Acquisition	Acquisition Bulldog Skincare Holdings, Limited On October 31, 2016, the Company completed the acquisition of Bulldog, a men's grooming and skincare products company based in the U.K., for £27.8 , or $34.0 , net of cash acquired. The acquisition creates opportunities to expand Edgewell's personal care portfolio into a growing global category where it can leverage its international geographic footprint. The acquisition was financed through available foreign cash. The Company has recognized the assets and liabilities of Bulldog based on preliminary estimates of their acquisition date fair values. The determination of the fair values of the acquired assets and assumed liabilities, including goodwill and other intangible assets, requires significant judgment. The Company is in the process of finalizing the analysis of its deferred tax positions; as such, this valuation analysis was not complete as of March 31, 2017. The Company expects to complete the final fair value determinations during the third quarter of fiscal 2017. The following presents the preliminary purchase price allocation: Cash $ 1.2 Inventory 2.5 Other assets 5.9 Goodwill 13.3 Other intangible assets 18.0 Liabilities (5.7 ) Net assets acquired $ 35.2 The intangible assets acquired consisted of customer relationships and product formulations, with a weighted-average useful life of 14.4 years , and the Bulldog trade name, which has been classified as an indefinite-lived intangible asset. The excess of the purchase price over net tangible and intangible assets acquired resulted in goodwill of $13.3 , which represents the value of the expansion into new markets and the acquired workforce of Bulldog, and is not expected to be deductible for tax purposes. All assets are included in the Company's Sun and Skin Care segment. Acquisition and integration costs related to the acquisition were not material.

Restructuring Charges

Restructuring Charges	6 Months Ended
Restructuring Charges	Mar. 31, 2017
Restructuring Charges [Abstract]
Restructuring Charges	Restructuring Charges Spin Restructuring The Company initiated certain restructuring activities related to the July 1, 2015 separation of its Household Products business into a separate, publicly-traded company (the "Spin") in order to prepare both businesses to operate as stand-alone entities. The restructuring activities included efforts to adapt the global go-to-market footprint to adjust to the future strategies and scale of each stand-alone business; centralize certain back-office functions to increase efficiencies; outsource certain non-core transactional activities; and reduce headcount to optimize the cost structures of each stand-alone business. As of March 31, 2017 and September 30, 2016, $1.0 and $5.2 of accrued Spin restructuring charges were included in Other current liabilities. Restructuring In November 2012, the Company's Board of Directors (the "Board") authorized an enterprise-wide restructuring plan (the "Restructuring"). The Restructuring originally included several initiatives focused on reducing costs in general and administrative functions, as well as reducing manufacturing and operating costs associated with the Company's discontinued operations. In January 2014, the Board authorized an expansion of scope of the previously announced Restructuring, which included rationalization and streamlining of the Edgewell operating facilities and other cost saving initiatives. Restructuring charges specific to Edgewell have primarily related to plant closure and accelerated depreciation charges and severance and related benefit costs. Project-to-date restructuring costs total $152.6 . The Company now expects full year restructuring costs to total $25.0 to $28.0 for 2017, and does not currently expect costs in future periods to be material. Due to a delay in the transition of manufacturing in the Company's Feminine Care segment from Montreal to Dover, Delaware, project costs have increased and some anticipated savings are now expected to be realized in fiscal 2019. Additionally, the Company's full year cost estimate for fiscal 2017 now includes a non-cash charge related to the disposition of real estate. The remainder of the Company's restructuring projects, which relate to Wet Shave and Sun Care footprint changes, are expected to be on schedule. Expenses incurred under the Restructuring plan are reflected below, including the estimated impact of allocating such charges to segment results. Restructuring charges were only allocated to the Company's Wet Shave, Sun and Skin Care and Feminine Care segments for the three and six months ended March 31, 2017 and 2016. The Company does not include restructuring costs in the results of its reportable segments. Three Months Ended March 31, 2017 Wet Sun and Skin Care Feminine Total Restructuring Severance and related benefit costs $ 0.3 $ — $ 0.9 $ 1.2 Asset impairment and accelerated depreciation — — 1.1 1.1 Consulting, program management and other exit costs 2.2 0.1 0.9 3.2 Total Restructuring $ 2.5 $ 0.1 $ 2.9 $ 5.5 Six Months Ended March 31, 2017 Wet Shave Sun and Skin Care Feminine Care Total Restructuring Severance and related benefit costs $ 0.7 $ — $ 2.4 $ 3.1 Asset impairment and accelerated depreciation — — 2.8 2.8 Consulting, program management and other exit costs 3.9 0.1 2.5 6.5 Total Restructuring $ 4.6 $ 0.1 $ 7.7 $ 12.4 Three Months Ended March 31, 2016 Wet Sun and Skin Care Feminine Total Restructuring Severance and related benefit costs $ (1.4 ) $ 0.2 $ 1.4 $ 0.2 Asset impairment and accelerated depreciation — — 0.5 0.5 Consulting, program management and other exit costs 1.3 0.1 2.9 4.3 Total Restructuring $ (0.1 ) $ 0.3 $ 4.8 $ 5.0 Six Months Ended March 31, 2016 Wet Shave Sun and Skin Care Feminine Care Total Restructuring Severance and related benefit costs $ 9.1 $ 0.2 $ 4.5 $ 13.8 Asset impairment and accelerated depreciation — — 1.2 1.2 Consulting, program management and other exit costs 2.0 0.1 6.4 8.5 Total Restructuring $ 11.1 $ 0.3 $ 12.1 $ 23.5 In addition, pre-tax costs of $0.1 and $0.4 for the three and six months ended March 31, 2017, respectively, associated with obsolescence charges related to the exit of certain non-core product lines as part of the restructuring were included in Cost of products sold. Obsolescence charges of $0.1 were recorded during the three and six months ended March 31, 2016. The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for the first six months of fiscal 2017: Utilized October 1, 2016 Charge to Other (1) Cash Non-Cash March 31, 2017 Restructuring Severance and termination related costs $ 16.7 $ 3.1 $ (0.6 ) $ (7.6 ) $ — $ 11.6 Asset impairment and accelerated depreciation — 2.8 — — (2.8 ) — Other related costs — 6.5 — (6.5 ) — — Total Restructuring $ 16.7 $ 12.4 $ (0.6 ) $ (14.1 ) $ (2.8 ) $ 11.6 (1) Includes the impact of currency translation. The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2016: Utilized October 1, 2015 Charge to Other (1) Cash Non-Cash September 30, 2016 Restructuring Severance and termination related costs $ 13.7 $ 17.0 $ 0.6 $ (14.6 ) $ — $ 16.7 Asset impairment and accelerated depreciation — 3.9 — — (3.9 ) — Other related costs — 16.1 — (16.1 ) — — Total Restructuring $ 13.7 $ 37.0 $ 0.6 $ (30.7 ) $ (3.9 ) $ 16.7 (1) Includes the impact of currency translation.

Income Taxes

Income Taxes	6 Months Ended
Income Taxes	Mar. 31, 2017
Income Taxes [Abstract]
Income Taxes	Income Taxes For the three and six months ended March 31, 2017, the Company had income tax expense of $23.8 and $35.2 , respectively, on Earnings before income taxes of $89.5 and $134.4 , respectively. The effective tax rate for the three and six months ended March 31, 2017 was 26.6% and 26.2% , respectively. The difference between the federal statutory rate and the effective rate for both periods is due to the mix of earnings in lower tax rate jurisdictions, and was favorably impacted by restructuring charges in higher tax rate jurisdictions. For the three and six months ended March 31, 2016, the Company had income tax expense of $25.2 and $32.2 , respectively, on Earnings before income taxes of $91.3 and $122.0 , respectively. The effective tax rate for the three and six months ended March 31, 2016 was 27.6% and 26.4% , respectively. The difference between the federal statutory rate and the effective rate for both periods is primarily due to the mix of earnings in lower tax rate jurisdictions and was favorably impacted by Spin costs and restructuring charges in higher tax rate jurisdictions.

Earnings per Share

Earnings per Share	6 Months Ended
Earnings per Share	Mar. 31, 2017
Earnings Per Share [Abstract]
Earnings per Share	Earnings per Share Basic earnings per share is based on the average number of common shares outstanding during the period. Diluted earnings per share is based on the average number of shares used for the basic earnings per share calculation, adjusted for the dilutive effect of share options and restricted share equivalent ("RSE") awards. Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended March 31, Six Months Ended March 31, 2017 2016 2017 2016 Basic weighted-average shares outstanding 57.4 59.4 57.5 59.6 Effect of dilutive securities: Share options — — — — RSE awards 0.3 0.5 0.3 0.5 Total dilutive securities 0.3 0.5 0.3 0.5 Diluted weighted-average shares outstanding 57.7 59.9 57.8 60.1 For the three and six months ended March 31, 2017 , the calculation of diluted weighted-average shares outstanding excludes 0.6 of share options because the effect of including these awards was anti-dilutive. For the three and six months ended March 31, 2016, the calculation of diluted weighted-average shares outstanding excludes 0.4 of share options and 0.1 of RSE awards because the effect of including these awards was anti-dilutive.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
Goodwill and Intangible Assets	Mar. 31, 2017
Goodwill and Intangibles [Abstract]
Goodwill and Intangible Assets	Goodwill and Intangible Assets The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Balance at October 1, 2016 $ 965.3 $ 178.0 $ 207.4 $ 69.6 $ 1,420.3 Acquisition of Bulldog — 13.3 — — 13.3 Cumulative translation adjustment (6.8 ) 0.4 (0.6 ) — (7.0 ) Balance at March 31, 2017 $ 958.5 $ 191.7 $ 206.8 $ 69.6 $ 1,426.6 Total amortizable intangible assets were as follows: March 31, 2017 September 30, 2016 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 45.4 $ 12.9 $ 32.5 $ 14.6 $ 12.2 $ 2.4 Technology and patents 77.1 71.5 5.6 76.9 69.8 7.1 Customer related and other 149.4 84.3 65.1 141.8 79.6 62.2 Total amortizable intangible assets $ 271.9 $ 168.7 $ 103.2 $ 233.3 $ 161.6 $ 71.7 Total amortizable intangible assets increased $8.9 with the acquisition of Bulldog, see Note 2 of Notes to Condensed Consolidated Financial Statements for more information. Amortization expense was $4.1 and $8.1 for the three and six months ended March 31, 2017 , respectively, and $3.6 and $7.2 for the three and six months ended March 31, 2016, respectively. Estimated amortization expense for amortizable intangible assets for the remainder of fiscal 2017 and for fiscal 2018, 2019, 2020, 2021 and 2022 is approximately $8.1 , $8.9 , $7.6 , $6.9 , $6.3 and $6.2 , respectively, and $59.2 thereafter. The Company had indefinite-lived intangible assets of $1,288.0 ( $224.1 in Wet Shave, $500.5 in Sun and Skin Care, $299.9 in Feminine Care and $263.5 in All Other) at March 31, 2017 , a decrease of $25.4 from September 30, 2016 . Indefinite-lived intangible assets decreased $30.9 due to the conversion of the Skintimate® brand name to a definite-lived intangible asset, as noted below, and changes in foreign currency translation rates, which were partially offset by the acquisition of the $9.1 indefinite-lived Bulldog tradename. See Note 2 of Notes to Condensed Consolidated Financial Statements for more information on the Bulldog acquisition. Goodwill and intangible assets deemed to have an indefinite life are not amortized, but reviewed annually during the fourth fiscal quarter for impairment of value or when indicators of a potential impairment are present. The Company continuously monitors changing business conditions, which may indicate that the remaining useful life of goodwill and other intangible assets may warrant revision or carrying amounts may require adjustment. During fiscal 2016 and 2015, the Company recorded impairment charges of $6.5 and $29.6 , respectively, on its Skintimate® brand name, which were primarily related to the introduction of competing products in the market, resulting in share and margin declines. Based on the impairments taken in the past two years and continued competitive pressure on this brand, as of October 1, 2016, the Skintimate® brand name was converted to a definite-lived asset and assigned a useful life of 20 years . This conversion to a definite-lived intangible asset increased amortization expense by $0.4 and $0.8 for the three and six months ended March 31, 2017, respectively. During fiscal 2015, the Company also recorded impairment charges related to its Playtex® and Wet Ones® brand names. As such, the fair value of both brand names continues to be relatively close to the carrying value and these assets will continue to be sensitive in the future to changes in forecasted cash flows, as well as other assumptions used in an impairment analysis, including discount rates.

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	6 Months Ended
Supplemental Balance Sheet Information	Mar. 31, 2017
Supplemental Financial Statement Information [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information March 31, September 30, Inventories Raw materials and supplies $ 56.9 $ 50.8 Work in process 49.6 43.9 Finished products 259.9 214.5 Total inventories $ 366.4 $ 309.2 Other Current Assets Miscellaneous receivables $ 35.8 $ 29.1 Prepaid expenses 62.2 49.0 Value added tax collectible from customers 23.7 22.4 Income taxes receivable 17.0 39.3 Other 4.1 3.4 Total other current assets $ 142.8 $ 143.2 Property, Plant and Equipment Land $ 23.1 $ 27.8 Buildings 141.6 146.0 Machinery and equipment 908.3 913.7 Capitalized software costs 40.5 38.4 Construction in progress 49.4 36.2 Total gross property 1,162.9 1,162.1 Accumulated depreciation (700.9 ) (676.0 ) Total property, plant and equipment, net $ 462.0 $ 486.1 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 50.0 $ 46.8 Accrued trade allowances 28.0 30.1 Accrued salaries, vacations and incentive compensation 33.0 56.0 Income taxes payable 23.5 19.7 Returns reserve 37.2 49.9 Restructuring reserve 12.6 21.9 Value added tax payable 30.8 25.0 Deferred compensation 5.7 26.1 Other 85.3 95.9 Total other current liabilities $ 306.1 $ 371.4 Other Liabilities Pensions and other retirement benefits $ 146.9 $ 154.9 Deferred compensation 54.8 58.6 Other non-current liabilities 60.5 61.3 Total other liabilities $ 262.2 $ 274.8

Debt

Debt	6 Months Ended
Debt	Mar. 31, 2017
Debt [Abstract]
Debt	Debt The detail of long-term debt was as follows: March 31, September 30, Senior notes, fixed interest rate of 4.7%, due 2021, net (1) $ 598.0 $ 597.8 Senior notes, fixed interest rate of 4.7%, due 2022, net (1) (2) 497.2 496.9 U.S. revolving credit facility due 2020 330.0 265.0 Netherlands revolving credit facility due 2017 — 281.8 Term loan, due 2019, net (1) 184.6 184.5 Total long-term debt, including current maturities 1,609.8 1,826.0 Less current portion — 281.8 Total long-term debt $ 1,609.8 $ 1,544.2 (1) At March 31, 2017 , the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.0 , $2.1 and $0.4 , respectively. At September 30, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.2 , $2.3 and $0.5 , respectively. (2) At March 31, 2017 and September 30, 2016, the balance for the senior notes due 2022 is reflected net of discount of $0.7 and $0.8 , respectively. The Company had outstanding international borrowings, recorded in Notes payable, of $19.7 and $18.5 as of March 31, 2017 and September 30, 2016 , respectively. Netherlands Revolving Credit Facility On October 20, 2016, the Company terminated its commitments under the Netherlands revolving credit facility and repaid all outstanding loans and other obligations in full, in the amount of €251.3 , or approximately $277.0 . U.S. Revolving Credit Facility On March 13, 2017, the Company, along with its wholly-owned subsidiary, Edgewell Personal Care Brands, LLC ("Brands"), entered into Amendment No. 3 to the Credit Agreement (the "Amendment"), amending the Credit Agreement dated June 1, 2015 (as amended, the "Credit Agreement"), and an Increasing Lender Support Supplement to the Credit Agreement (the "Supplement"). The Amendment and the Supplement provide for an increase of $75.0 (from $650.0 to $725.0 ) in the revolving loans available to the Company and Brands. Additionally, certain other changes were made to the Credit Agreement, including allowing the Company to enter into receivables sales facilities for up to $150.0 of receivables.

Retirement Plans

Retirement Plans	6 Months Ended
Retirement Plans	Mar. 31, 2017
Pension and Other Postretirement Benefits [Abstract]
Retirement Plans	Retirement Plans The Company has several defined benefit pension plans covering employees in the U.S. and certain employees in other countries. The plans provide retirement benefits based on years of service and earnings. The Company also sponsors or participates in a number of other non-U.S. pension and postretirement arrangements, including various retirement and termination benefit plans, some of which are required by local law or coordinated with government-sponsored plans, which are not significant in the aggregate and, therefore, are not included in the information presented below. The Company's net periodic pension and postretirement benefit (credit) cost for these plans was as follows: Three Months Ended March 31, Six Months Ended March 31, 2017 2016 2017 2016 Service cost $ 1.9 $ 1.3 $ 3.7 $ 2.6 Interest cost 3.7 5.6 7.5 11.1 Expected return on plan assets (8.0 ) (7.7 ) (15.9 ) (14.6 ) Amortization of unrecognized prior service cost — — — — Recognized net actuarial loss 1.5 1.0 3.0 2.0 Settlement loss recognized — — 0.3 — Net periodic benefit (credit) cost $ (0.9 ) $ 0.2 $ (1.4 ) $ 1.1 In fiscal 2017, the Company changed the methodology used to estimate the service and interest components of net periodic benefit (credit) cost for its pension and postretirement benefits, which will result in a decrease in expense of approximately $4 during fiscal 2017. The Company believes the spot discount rate approach, which applies the specific spot rates along the yield curve used in the determination of the benefit obligations to the relevant cash flows, is a more precise application of the yield curve spot rates used in the traditional single discount rate approach. The change was accounted for prospectively as a change in accounting estimate.

Shareholders' Equity

Shareholders' Equity	6 Months Ended
Shareholders' Equity	Mar. 31, 2017
Shareholders' Equity [Abstract]
Shareholders' Equity	Shareholders' Equity In May 2015, the Board approved an authorization to repurchase up to 10.0 shares of the Company's common stock. This authorization replaced a prior share repurchase authorization. During the six months ended March 31, 2017 , the Company repurchased 0.8 shares of its common stock for $58.5 , all of which were purchased under this authorization. The Company has 4.7 shares remaining under the Board authorization to repurchase its common shares in the future. Future share repurchases, if any, would be made in the open market, privately negotiated transactions or otherwise, in such amounts and at such times as the Company deems appropriate based upon prevailing market conditions, business needs and other factors. During the six months ended March 31, 2017 , 0.2 shares were purchased related to the surrender of shares of common stock to satisfy tax withholding obligations in connection with the vesting of RSE awards. During the six months ended March 31, 2017, the Company paid $0.8 cash dividends related to the vesting of RSE awards, which had been declared and accrued during prior fiscal years. The Company has not declared any dividends since the third quarter of fiscal 2015, and does not currently intend to declare dividends in the foreseeable future.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
Accumulated Other Comprehensive Loss	Mar. 31, 2017
Accumulated Other Comprehensive (Loss) Income [Abstract]
Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss The following table presents the changes in accumulated other comprehensive loss ("AOCI"), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2016 $ (68.1 ) $ (126.3 ) $ (2.8 ) $ (197.2 ) OCI before reclassifications (1) (28.7 ) 2.3 3.6 (22.8 ) Reclassifications to earnings — 2.2 0.9 3.1 Balance at March 31, 2017 $ (96.8 ) $ (121.8 ) $ 1.7 $ (216.9 ) Foreign Pension and Hedging Total Balance at October 1, 2015 $ (69.1 ) $ (105.7 ) $ 3.3 $ (171.5 ) OCI before reclassifications (1) 7.3 (7.3 ) (9.4 ) (9.4 ) Reclassifications to earnings — 1.3 3.2 4.5 Balance at March 31, 2016 $ (61.8 ) $ (111.7 ) $ (2.9 ) $ (176.4 ) (1) OCI is defined as other comprehensive income (loss). The following table presents the reclassifications out of AOCI: For the Three Months Ended For the Six Months Ended March 31, Affected Line Item in the Condensed Consolidated Statements of Earnings Details of AOCI Components 2017 2016 2017 2016 Gains and losses on cash flow hedges Foreign exchange contracts $ 1.7 $ 1.0 $ 1.4 $ 4.6 Other income, net 1.7 1.0 1.4 4.6 Total before tax (0.6 ) (0.3 ) (0.5 ) (1.4 ) Tax expense 1.1 0.7 0.9 3.2 Net of tax Amortization of defined benefit pension and postretirement items Prior service costs — — — — (1) Actuarial losses 1.5 1.0 3.0 2.0 (1) Settlement loss recognized — — 0.3 — (1) 1.5 1.0 3.3 2.0 Total before tax (0.5 ) (0.3 ) (1.1 ) (0.7 ) Tax expense 1.0 0.7 2.2 1.3 Net of tax Total reclassifications for the period $ 2.1 $ 1.4 $ 3.1 $ 4.5 Net of tax (1) These AOCI components are included in the computation of net periodic benefit (credit) cost. See Note 9 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Risk

Financial Instruments and Risk Management	6 Months Ended
Financial Instruments and Risk Management	Mar. 31, 2017
Financial Instruments and Risk Management [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management At times, the Company enters into contractual arrangements (derivatives) to reduce its exposure to foreign currency and interest rate risks. The section below outlines the types of derivatives that existed at March 31, 2017 and September 30, 2016 , as well as the Company's objectives and strategies for holding derivative instruments. Foreign Currency Risk A significant share of the Company's sales are tied to currencies other than the U.S. dollar, the Company's reporting currency. As such, a weakening of currencies relative to the U.S. dollar can have a negative impact to reported earnings. Conversely, strengthening of currencies relative to the U.S. dollar can improve reported results. The primary currencies to which the Company is exposed include the Euro, the Japanese Yen, the British Pound, the Canadian Dollar and the Australian Dollar. Additionally, the Company's foreign subsidiaries enter into internal and external transactions that create non-functional currency balance sheet positions at the foreign subsidiary level. These exposures are generally the result of intercompany purchases, intercompany loans and, to a lesser extent, external purchases, and are revalued in the foreign subsidiary's local currency at the end of each period. Changes in the value of the non-functional currency balance sheet positions in relation to the foreign subsidiary's local currency results in an exchange gain or loss recorded in Other income, net. The primary currency to which the Company's foreign subsidiaries are exposed is the U.S. dollar. Interest Rate Risk The Company has interest rate risk with respect to interest expense on variable rate debt. At March 31, 2017 , the Company had $514.6 of variable rate debt outstanding, which consisted of outstanding borrowings under the Company's revolving credit facility in the U.S. and term loan. Cash Flow Hedges At March 31, 2017 , the Company maintained a cash flow hedging program related to foreign currency risk. These derivative instruments have a high correlation to the underlying exposure being hedged and have been deemed highly effective for accounting purposes in offsetting the associated risk. The Company entered into a series of forward currency contracts to hedge cash flow uncertainty associated with currency fluctuations. These transactions are accounted for as cash flow hedges. The Company had an unrealized pre-tax gain of $2.5 at March 31, 2017 compared to an unrealized loss of $4.3 at September 30, 2016 on these forward currency contracts accounted for as cash flow hedges included in AOCI. Assuming foreign exchange rates versus the U.S. dollar remain at March 31, 2017 levels over the next twelve months, the majority of the pre-tax loss included in AOCI at March 31, 2017 is expected to be included in Other income, net. Contract maturities for these hedges extend into fiscal 2018. There were 69 open foreign currency contracts at March 31, 2017 with a total notional value of $131.5 . Derivatives not Designated as Hedges The Company entered into foreign currency derivative contracts which are not designated as cash flow hedges for accounting purposes to hedge balance sheet exposures. Any gains or losses on these contracts are expected to be offset by exchange gains or losses on the underlying exposures, thus they are not subject to significant market risk. The change in estimated fair value of the foreign currency contracts for the three and six months ended March 31, 2017 resulted in a loss of $2.2 and a gain $0.4 and was recorded in Other income, net. The change in estimated fair value of the foreign currency contracts for the three and six months ended March 31, 2016 resulted in a loss of $4.3 . There were five open foreign currency derivative contracts, which were not designated as cash flow hedges at March 31, 2017 , with a total notional value of $85.3 . The following table provides estimated fair values and the amounts of gains and losses on derivative instruments classified as cash flow hedges: At March 31, 2017 For the Three Months Ended For the Six Months Ended Derivatives designated as cash flow hedging relationships Estimated Fair Value, Asset (1) (2) Loss Recognized in OCI Gain Reclassified From OCI into Income (Effective Portion) (3) (4) Gain Recognized in OCI Gain Reclassified From OCI into Income (Effective (3) (4) Foreign currency contracts $ 2.5 $ (3.5 ) $ 1.7 $ 8.2 $ 1.4 At September 30, 2016 For the Three Months Ended For the Six Months Ended Derivatives designated as cash flow hedging relationships Estimated (1) (2) Loss Recognized Gain Reclassified From OCI into Income (Effective Portion) (3) (4) Loss Recognized Gain Reclassified From OCI into Income (Effective (3) (4) Foreign currency contracts $ (4.3 ) $ (5.3 ) $ 1.0 $ (4.5 ) $ 4.6 (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities. (3) (Loss) gain reclassified to income was recorded in Other income, net. (4) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk. The following table provides estimated fair values and the amounts of gains and losses on derivative instruments not classified as cash flow hedges: At March 31, 2017 For the Three Months Ended March 31, 2017 For the Six Months Ended March 31, 2017 Derivatives not designated as cash flow hedging relationships Estimated Fair Value, Asset Loss Recognized in Income (1) Gain Recognized in Income (1) Foreign currency contracts $ (2.0 ) $ (2.2 ) $ 0.4 At September 30, 2016 For the Three Months Ended March 31, 2016 For the Six Months Ended March 31, 2016 Derivatives not designated as cash flow hedging relationships Estimated Fair Value, Liability Loss Recognized in Income (1) Loss Recognized in Income (1) Foreign currency contracts $ (1.3 ) $ (4.3 ) $ (4.3 ) (1) (Loss) gain recognized in income was recorded in Other income, net. The following table provides financial assets and liabilities for balance sheet offsetting: Offsetting of derivative assets At March 31, 2017 At September 30, 2016 Description Balance Sheet location Gross amounts of recognized assets Gross amounts offset in the Balance Sheet Net amounts of assets presented in the Balance Sheet Gross amounts of recognized assets Gross amounts offset in the Balance Sheet Net amounts of assets presented in the Balance Sheet Foreign currency contracts Other current assets, Other assets $ 3.5 $ (0.7 ) $ 2.8 $ 1.7 $ — $ 1.7 Offsetting of derivative liabilities At March 31, 2017 At September 30, 2016 Description Balance Sheet location Gross amounts of recognized liabilities Gross amounts offset in the Balance Sheet Net amounts of liabilities presented in the Balance Sheet Gross amounts of recognized liabilities Gross amounts offset in the Balance Sheet Net amounts of liabilities presented in the Balance Sheet Foreign currency contracts Other current liabilities, Other liabilities $ (2.4 ) $ 0.1 $ (2.3 ) $ (6.2 ) $ 0.2 $ (6.0 ) Fair Value Hierarchy Accounting guidance on fair value measurements for certain financial assets and liabilities requires that assets and liabilities carried at fair value be classified in one of the following three categories: Level 1: Quoted market prices in active markets for identical assets or liabilities. Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data. Level 3: Unobservable inputs reflecting the reporting entity's own assumptions or external inputs from inactive markets. Under the fair value accounting guidance hierarchy, an entity is required to maximize the use of quoted market prices and minimize the use of unobservable inputs. The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy: March 31, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation $ (60.1 ) $ (84.5 ) Derivatives - foreign currency contracts 0.5 (5.6 ) Net liabilities at estimated fair value $ (59.6 ) $ (90.1 ) At March 31, 2017 and September 30, 2016 , the Company had no level 1 or level 3 financial assets or liabilities, other than pension plan assets. At March 31, 2017 and September 30, 2016 , the fair market value of fixed rate long-term debt was $1,136.9 and $1,106.2 , respectively, compared to its carrying value of $1,095.2 and $ 1,094.7 , respectively. The estimated fair value of the long-term debt is estimated using yields obtained from independent pricing sources for similar types of borrowing arrangements. The estimated fair value of variable-rate debt, excluding revolving credit facilities, which consists of bank debt, was $185.0 compared to its carrying value of $184.6 and $184.5 at March 31, 2017 and September 30, 2016, respectively. The estimated fair value is equal to the face value of the debt. The estimated fair value of long-term debt, excluding revolving credit facilities, have been determined based on level 2 inputs. Due to the nature of cash and cash equivalents and short-term borrowings, including notes payable, carrying amounts on the balance sheets approximate fair value. Additionally, the carrying amounts of the Company's revolving credit facilities, which are classified as long-term debt on the balance sheet, approximate fair value due to the revolving nature of the balances. The estimated fair value of cash and cash equivalents, short-term borrowings and the revolving credit agreements have been determined based on level 2 inputs. At March 31, 2017 , the estimated fair value of foreign currency contracts is the amount that the Company would receive or pay to terminate the contracts, considering first the quoted market prices of comparable agreements or, in the absence of quoted market prices, factors such as interest rates, currency exchange rates and remaining maturities. The estimated fair value of the deferred compensation liability is determined based upon the quoted market prices of the investment options that are offered under the plan.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Mar. 31, 2017
Legal Proceedings and Contingencies [Abstract]
Commitments and Contingencies	Commitments and Contingencies The Company and its affiliates are subject to a number of legal proceedings in various jurisdictions arising out of its operations during the ordinary course of business. Many of these legal matters are in preliminary stages and involve complex issues of law and fact, and may proceed for protracted periods of time. The amount of liability, if any, from these proceedings cannot be determined with certainty. The Company reviews its legal proceedings and claims, regulatory reviews and inspections and other legal proceedings on an ongoing basis and follows appropriate accounting guidance when making accrual and disclosure decisions. The Company establishes accruals for those contingencies when the incurrence of a loss is probable and can be reasonably estimated, and discloses the amount accrued and the amount of a reasonably possible loss in excess of the amount accrued, if such disclosure is necessary for its financial statements to not be misleading. The Company does not record liabilities when the likelihood that the liability has been incurred is probable, if the amount cannot be reasonably estimated. Based upon present information, the Company believes that its liability, if any, arising from such pending legal proceedings, asserted legal claims and known potential legal claims, which are likely to be asserted, is not reasonably likely to be material to the Company's financial position, results of operations or cash flows, taking into account established accruals for estimated liabilities.

Segment Data

Segment Data	6 Months Ended
Segment Data	Mar. 31, 2017
Segments [Abstract]
Segment Data	Segment Data The Company conducts its business in the following four segments: • Wet Shave consists of products sold under the Schick®, Wilkinson Sword®, Edge®, Skintimate®, Shave Guard and Personna® brands, as well as non-branded products. The Company's wet shave products include razor handles and refillable blades, disposable shave products and shaving gels and creams. • Sun and Skin Care consists of Banana Boat® and Hawaiian Tropic® sun care products and Bulldog® men's skin care products, as well as Wet Ones® wipes and Playtex® household gloves. • Feminine Care includes tampons, pads and liners sold under the Playtex® Sport®, Stayfree®, Carefree® and o.b.® brands, as well as personal cleansing wipes under the Playtex® brand. • All Other includes infant care products, such as bottles, cups and pacifiers, under the Playtex®, OrthoPro® and Binky® brand names, as well as the Diaper Genie® and Litter Genie® disposal systems. Segment performance is evaluated based on segment profit, exclusive of general corporate expenses, share-based compensation costs, costs associated with restructuring initiatives, the sale of the industrial blade business and the amortization of intangible assets. Financial items, such as interest income and expense, are managed on a global basis at the corporate level. The exclusion of such charges from segment results reflects management's view on how it evaluates segment performance. The Company's operating model includes some shared business functions across the segments, including product warehousing and distribution, transaction processing functions and in most cases a combined sales force and management teams. The Company applies a fully allocated cost basis, in which shared business functions are allocated between the segments. Such allocations are estimates, and do not represent the costs of such services if performed on a stand-alone basis. Segment net sales and profitability are presented below: Three Months Ended March 31, Six Months Ended March 31, 2017 2016 2017 2016 Net Sales Wet Shave $ 342.6 $ 353.4 $ 648.8 $ 669.7 Sun and Skin Care 150.6 132.5 208.2 186.0 Feminine Care 83.2 91.6 172.3 184.1 All Other 34.6 33.7 66.7 66.5 Total net sales $ 611.0 $ 611.2 $ 1,096.0 $ 1,106.3 Segment Profit Wet Shave $ 73.2 $ 77.7 $ 145.2 $ 144.5 Sun and Skin Care 50.9 39.2 51.7 40.9 Feminine Care 1.6 10.5 9.9 28.1 All Other 7.7 8.0 14.6 15.2 Total segment profit 133.4 135.4 221.4 228.7 General corporate and other expenses (23.5 ) (20.3 ) (39.9 ) (38.0 ) Spin costs (1) — (1.7 ) — (9.2 ) Restructuring and related costs (2) (5.6 ) (5.1 ) (12.8 ) (23.6 ) Industrial sale charges — (0.2 ) — (0.2 ) Amortization of intangibles (4.1 ) (3.6 ) (8.1 ) (7.2 ) Interest and other expense, net (10.7 ) (13.2 ) (26.2 ) (28.5 ) Total earnings before income taxes $ 89.5 $ 91.3 $ 134.4 $ 122.0 (1) Includes pre-tax Selling, general and administrative expense of $1.7 and $9.0 , respectively, and pre-tax Cost of products sold of $0.2 for the six months ended March 31, 2016 related to the separation of the Household Products business in July 2015. (2) Includes pre-tax Cost of products sold of $0.1 and $0.4 for the three and six months ended March 31, 2017, respectively, and $0.1 for the three and six months ended March 31, 2016 associated with obsolescence charges related to the exit of certain non-core product lines as a part of restructuring. Supplemental product information is presented below for net sales: Three Months Ended Six Months Ended 2017 2016 2017 2016 Razors and blades $ 305.6 $ 315.7 $ 576.9 $ 589.8 Tampons, pads and liners 83.2 91.6 172.3 184.1 Sun care products 131.2 114.9 168.9 151.8 Infant care and other 34.6 33.7 66.7 66.5 Shaving gels and creams 37.0 37.7 71.9 79.9 Skin care products 19.4 17.6 39.3 34.2 Total net sales $ 611.0 $ 611.2 $ 1,096.0 $ 1,106.3

Guarantor and Non-Guarantor Fin

Guarantor and Non-Guarantor Financial Information	6 Months Ended
Guarantor and Non-Guarantor Financial Information	Mar. 31, 2017
Guarantor and Non-Guarantor Financial Information [Abstract]
Guarantor and Non-Guarantor Financial Information	Guarantor and Non-Guarantor Financial Information The Company's senior notes issued in May 2011 and May 2012 (collectively, the "Notes") are fully and unconditionally guaranteed on a joint and several basis by the Company's existing and future direct and indirect domestic subsidiaries that are guarantors of any of the Company's credit agreements or other indebtedness for borrowed money (the "Guarantors"). The Guarantors are 100% owned either directly or indirectly by the Company and jointly and severally guarantee the Company's obligations under the Notes and substantially all of the Company's other outstanding indebtedness. The Company's subsidiaries organized outside of the U.S. and certain domestic subsidiaries which are not guarantors of any of the Company's other indebtedness (collectively, the "Non-Guarantors"), do not guarantee the Notes. The subsidiary guarantee with respect to the Notes is subject to release upon sale of all of the capital stock of the Subsidiary Guarantor; if the guarantee under the Company's credit agreements and other indebtedness for borrowed money is released or discharged (other than due to payment under such guarantee); or when the requirements for legal defeasance are satisfied or the obligations are discharged in accordance with the indenture. Set forth below are the condensed consolidating financial statements presenting the results of operations, financial position and cash flows of the Parent Company, Edgewell Personal Care Company, the Guarantors on a combined basis, the Non-Guarantors on a combined basis and eliminations necessary to arrive at the information for the Company, as reported on a consolidated basis. Eliminations represent adjustments to eliminate investments in subsidiaries and intercompany balances and transactions between or among the Parent Company, the Guarantors and the Non-Guarantors. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended March 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 433.4 $ 275.6 $ (98.0 ) $ 611.0 Cost of products sold — 237.0 162.4 (98.0 ) 301.4 Gross profit — 196.4 113.2 — 309.6 Selling, general and administrative expense — 69.9 34.0 — 103.9 Advertising and sales promotion expense — 52.7 29.8 — 82.5 Research and development expense — 17.3 0.2 — 17.5 Restructuring charges — 2.2 3.3 — 5.5 Interest expense associated with debt 13.3 3.8 0.2 — 17.3 Other income, net — (0.4 ) (6.2 ) — (6.6 ) Intercompany service fees — (8.1 ) 8.1 — — Equity in earnings of subsidiaries (74.1 ) (36.3 ) — 110.4 — Earnings before income taxes 60.8 95.3 43.8 (110.4 ) 89.5 Income tax (benefit) provision (4.9 ) 21.0 7.7 — 23.8 Net earnings $ 65.7 $ 74.3 $ 36.1 $ (110.4 ) $ 65.7 Statement of Comprehensive Income: Net earnings $ 65.7 $ 74.3 $ 36.1 $ (110.4 ) $ 65.7 Other comprehensive income (loss), net of tax 7.2 (16.5 ) 6.7 9.8 7.2 Total comprehensive income $ 72.9 $ 57.8 $ 42.8 $ (100.6 ) $ 72.9 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Six Months Ended March 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 776.3 $ 507.9 $ (188.2 ) $ 1,096.0 Cost of products sold — 441.5 305.1 (188.2 ) 558.4 Gross profit — 334.8 202.8 — 537.6 Selling, general and administrative expense — 128.6 69.1 — 197.7 Advertising and sales promotion expense — 82.9 50.2 — 133.1 Research and development expense — 33.3 0.5 — 33.8 Restructuring charges — 4.9 7.5 — 12.4 Interest expense associated with debt 26.7 7.1 0.9 — 34.7 Other income, net — — (8.5 ) — (8.5 ) Intercompany service fees — (12.5 ) 12.5 — — Equity in earnings of subsidiaries (116.0 ) (57.4 ) — 173.4 — Earnings before income taxes 89.3 147.9 70.6 (173.4 ) 134.4 Income tax (benefit) provision (9.9 ) 31.9 13.2 — 35.2 Net earnings $ 99.2 $ 116.0 $ 57.4 $ (173.4 ) $ 99.2 Statement of Comprehensive Income: Net earnings $ 99.2 $ 116.0 $ 57.4 $ (173.4 ) $ 99.2 Other comprehensive loss, net of tax (19.7 ) (19.7 ) (21.1 ) 40.8 (19.7 ) Total comprehensive income $ 79.5 $ 96.3 $ 36.3 $ (132.6 ) $ 79.5 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended March 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 440.1 $ 289.2 $ (118.1 ) $ 611.2 Cost of products sold — 246.4 171.4 (117.7 ) 300.1 Gross profit — 193.7 117.8 (0.4 ) 311.1 Selling, general and administrative expense 0.8 67.0 31.9 — 99.7 Advertising and sales promotion expense — 56.1 29.0 (0.1 ) 85.0 Research and development expense — 16.3 0.4 — 16.7 Restructuring charges — 3.9 1.1 — 5.0 Industrial sale charges — 0.2 — — 0.2 Interest expense associated with debt 11.3 4.7 1.8 — 17.8 Other income, net — (2.8 ) (1.8 ) — (4.6 ) Intercompany service fees — (3.9 ) 3.9 — — Equity in earnings of subsidiaries (73.7 ) (37.4 ) — 111.1 — Earnings before income taxes 61.6 89.6 51.5 (111.4 ) 91.3 Income tax (benefit) provision (4.5 ) 19.6 10.4 (0.3 ) 25.2 Net earnings $ 66.1 $ 70.0 $ 41.1 $ (111.1 ) $ 66.1 Statement of Comprehensive Income: Net earnings 66.1 70.0 41.1 (111.1 ) 66.1 Other comprehensive income (loss), net of tax 7.0 (9.8 ) 7.3 2.5 7.0 Total comprehensive income $ 73.1 $ 60.2 $ 48.4 $ (108.6 ) $ 73.1 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Six Months Ended March 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 776.9 $ 558.7 $ (229.3 ) $ 1,106.3 Cost of products sold — 451.3 346.2 (229.8 ) 567.7 Gross profit — 325.6 212.5 0.5 538.6 Selling, general and administrative expense 3.9 127.7 68.5 — 200.1 Advertising and sales promotion expense — 83.6 48.2 (0.2 ) 131.6 Research and development expense — 31.9 0.8 — 32.7 Restructuring charges — 8.6 14.9 — 23.5 Industrial sale charges — 0.2 — — 0.2 Interest expense associated with debt 27.5 4.7 3.3 — 35.5 Other income, net — (5.2 ) (1.8 ) — (7.0 ) Intercompany service fees — (9.4 ) 9.4 — — Equity in earnings of subsidiaries (109.5 ) (49.8 ) — 159.3 — Earnings before income taxes 78.1 133.3 69.2 (158.6 ) 122.0 Income tax (benefit) provision (11.7 ) 29.6 13.6 0.7 32.2 Net earnings $ 89.8 $ 103.7 $ 55.6 $ (159.3 ) $ 89.8 Statement of Comprehensive Income: Net earnings 89.8 103.7 55.6 (159.3 ) 89.8 Other comprehensive loss, net of tax (4.9 ) (11.7 ) (4.2 ) 15.9 (4.9 ) Total comprehensive income $ 84.9 $ 92.0 $ 51.4 $ (143.4 ) $ 84.9 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS March 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 14.9 $ 388.0 $ — $ 402.9 Trade receivables, net — 164.9 146.1 — 311.0 Inventories — 226.8 139.6 — 366.4 Other current assets — 41.2 101.6 — 142.8 Total current assets — 447.8 775.3 — 1,223.1 Investment in subsidiaries 3,580.0 1,194.4 — (4,774.4 ) — Intercompany receivables, net (1) — 556.4 59.9 (616.3 ) — Intercompany notes receivable (1) — 1.9 — (1.9 ) — Property, plant and equipment, net — 332.6 129.4 — 462.0 Goodwill — 1,061.8 364.8 — 1,426.6 Other intangible assets, net — 1,227.9 163.3 — 1,391.2 Other assets 1.9 0.1 25.7 — 27.7 Total assets $ 3,581.9 $ 4,822.9 $ 1,518.4 $ (5,392.6 ) $ 4,530.6 Liabilities and Shareholders' Equity Current liabilities $ 20.9 $ 274.0 $ 262.5 $ — $ 557.4 Intercompany payables, net (1) 616.3 — — (616.3 ) — Intercompany notes payable (1) — — 1.9 (1.9 ) — Long-term debt 1,094.8 515.0 — — 1,609.8 Deferred income tax liabilities — 227.6 24.1 — 251.7 Other liabilities 0.4 226.3 35.5 — 262.2 Total liabilities 1,732.4 1,242.9 324.0 (618.2 ) 2,681.1 Total shareholders' equity 1,849.5 3,580.0 1,194.4 (4,774.4 ) 1,849.5 Total liabilities and shareholders' equity $ 3,581.9 $ 4,822.9 $ 1,518.4 $ (5,392.6 ) $ 4,530.6 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 5.8 $ 733.1 $ — $ 738.9 Trade receivables, net — 108.9 151.8 — 260.7 Inventories — 187.7 121.5 — 309.2 Other current assets — 43.7 99.5 — 143.2 Total current assets — 346.1 1,105.9 — 1,452.0 Investment in subsidiaries 3,483.7 825.0 — (4,308.7 ) — Intercompany receivables, net (1) — 487.6 53.5 (541.1 ) — Intercompany notes receivable (1) — 1.9 — (1.9 ) — Property, plant and equipment, net — 343.8 142.3 — 486.1 Goodwill — 1,061.9 358.4 — 1,420.3 Other intangible assets, net — 1,235.1 150.0 — 1,385.1 Other assets 2.0 0.1 25.9 — 28.0 Total assets $ 3,485.7 $ 4,301.5 $ 1,836.0 $ (4,851.7 ) $ 4,771.5 Liabilities and Shareholders' Equity Current liabilities $ 21.4 $ 288.4 $ 558.4 $ — $ 868.2 Intercompany payables, net (1) 541.1 — — (541.1 ) — Intercompany notes payable (1) — — 1.9 (1.9 ) — Long-term debt 1,094.2 450.0 — — 1,544.2 Deferred income tax liabilities — 232.4 22.9 — 255.3 Other liabilities — 236.3 38.5 — 274.8 Total liabilities 1,656.7 1,207.1 621.7 (543.0 ) 2,942.5 Total shareholders' equity 1,829.0 3,094.4 1,214.3 (4,308.7 ) 1,829.0 Total liabilities and shareholders' equity $ 3,485.7 $ 4,301.5 $ 1,836.0 $ (4,851.7 ) $ 4,771.5 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Six Months Ended March 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from (used by) operations $ 56.5 $ (36.5 ) $ 49.6 $ (70.0 ) $ (0.4 ) Cash Flow from Investing Activities Capital expenditures — (25.0 ) (5.4 ) — (30.4 ) Acquisitions, net of cash acquired — — (34.0 ) — (34.0 ) Proceeds from sale of assets — 5.9 — — 5.9 Net cash used by investing activities — (19.1 ) (39.4 ) — (58.5 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 181.0 — — 181.0 Cash payments on debt with original maturities greater than 90 days — (116.0 ) (277.0 ) — (393.0 ) Net (decrease) increase in debt with original maturities of 90 days or less — (0.3 ) 1.5 — 1.2 Common shares purchased (58.5 ) — — — (58.5 ) Intercompany dividend — — (70.0 ) 70.0 — Other, net 2.0 — — — 2.0 Net cash (used by) from financing activities (56.5 ) 64.7 (345.5 ) 70.0 (267.3 ) Effect of exchange rate changes on cash — — (9.8 ) — (9.8 ) Net increase (decrease) in cash and cash equivalents — 9.1 (345.1 ) — (336.0 ) Cash and cash equivalents, beginning of period — 5.8 733.1 — 738.9 Cash and cash equivalents, end of period $ — $ 14.9 $ 388.0 $ — $ 402.9 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Six Months Ended March 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from (used by) operations $ 78.9 $ (74.5 ) $ (77.0 ) $ — $ (72.6 ) Cash Flow from Investing Activities Capital expenditures — (30.7 ) (3.8 ) — (34.5 ) Payment for equity contributions — (0.5 ) — 0.5 — Net cash used by investing activities — (31.2 ) (3.8 ) 0.5 (34.5 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 391.0 4.3 — 395.3 Cash payments on debt with original maturities greater than 90 days — (261.0 ) — — (261.0 ) Net decrease in debt with original maturities of 90 days or less — (5.3 ) (0.3 ) — (5.6 ) Common shares purchased (78.9 ) — — — (78.9 ) Proceeds for equity contributions — — 0.5 (0.5 ) — Net cash (used by) from financing activities (78.9 ) 124.7 4.5 (0.5 ) 49.8 Effect of exchange rate changes on cash — — 5.7 — 5.7 Net increase (decrease) in cash and cash equivalents — 19.0 (70.6 ) — (51.6 ) Cash and cash equivalents, beginning of period — 2.9 709.2 — 712.1 Cash and cash equivalents, end of period $ — $ 21.9 $ 638.6 $ — $ 660.5

Acquisition (Tables)

Acquisition (Tables)	6 Months Ended
Acquisition (Tables)	Mar. 31, 2017
Acquisition [Abstract]
Schedule of Purchase Price Allocation	The following presents the preliminary purchase price allocation: Cash $ 1.2 Inventory 2.5 Other assets 5.9 Goodwill 13.3 Other intangible assets 18.0 Liabilities (5.7 ) Net assets acquired $ 35.2

Restructuring Charges (Tables)

Restructuring Charges (Tables)	6 Months Ended
Restructuring Charges (Tables)	Mar. 31, 2017
Restructuring Charges [Abstract]
Schedule of Charges Related to Restructuring Activities	Expenses incurred under the Restructuring plan are reflected below, including the estimated impact of allocating such charges to segment results. Restructuring charges were only allocated to the Company's Wet Shave, Sun and Skin Care and Feminine Care segments for the three and six months ended March 31, 2017 and 2016. The Company does not include restructuring costs in the results of its reportable segments. Three Months Ended March 31, 2017 Wet Sun and Skin Care Feminine Total Restructuring Severance and related benefit costs $ 0.3 $ — $ 0.9 $ 1.2 Asset impairment and accelerated depreciation — — 1.1 1.1 Consulting, program management and other exit costs 2.2 0.1 0.9 3.2 Total Restructuring $ 2.5 $ 0.1 $ 2.9 $ 5.5 Six Months Ended March 31, 2017 Wet Shave Sun and Skin Care Feminine Care Total Restructuring Severance and related benefit costs $ 0.7 $ — $ 2.4 $ 3.1 Asset impairment and accelerated depreciation — — 2.8 2.8 Consulting, program management and other exit costs 3.9 0.1 2.5 6.5 Total Restructuring $ 4.6 $ 0.1 $ 7.7 $ 12.4 Three Months Ended March 31, 2016 Wet Sun and Skin Care Feminine Total Restructuring Severance and related benefit costs $ (1.4 ) $ 0.2 $ 1.4 $ 0.2 Asset impairment and accelerated depreciation — — 0.5 0.5 Consulting, program management and other exit costs 1.3 0.1 2.9 4.3 Total Restructuring $ (0.1 ) $ 0.3 $ 4.8 $ 5.0 Six Months Ended March 31, 2016 Wet Shave Sun and Skin Care Feminine Care Total Restructuring Severance and related benefit costs $ 9.1 $ 0.2 $ 4.5 $ 13.8 Asset impairment and accelerated depreciation — — 1.2 1.2 Consulting, program management and other exit costs 2.0 0.1 6.4 8.5 Total Restructuring $ 11.1 $ 0.3 $ 12.1 $ 23.5
Schedule of Restructuring Activities and Related Accruals	The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for the first six months of fiscal 2017: Utilized October 1, 2016 Charge to Other (1) Cash Non-Cash March 31, 2017 Restructuring Severance and termination related costs $ 16.7 $ 3.1 $ (0.6 ) $ (7.6 ) $ — $ 11.6 Asset impairment and accelerated depreciation — 2.8 — — (2.8 ) — Other related costs — 6.5 — (6.5 ) — — Total Restructuring $ 16.7 $ 12.4 $ (0.6 ) $ (14.1 ) $ (2.8 ) $ 11.6 (1) Includes the impact of currency translation. The following table summarizes the Restructuring activities and related accrual (excluding certain obsolescence charges related to the restructuring) for fiscal 2016: Utilized October 1, 2015 Charge to Other (1) Cash Non-Cash September 30, 2016 Restructuring Severance and termination related costs $ 13.7 $ 17.0 $ 0.6 $ (14.6 ) $ — $ 16.7 Asset impairment and accelerated depreciation — 3.9 — — (3.9 ) — Other related costs — 16.1 — (16.1 ) — — Total Restructuring $ 13.7 $ 37.0 $ 0.6 $ (30.7 ) $ (3.9 ) $ 16.7 (1) Includes the impact of currency translation.

Earnings per Share (Tables)

Earnings per Share (Tables)	6 Months Ended
Earnings per Share (Tables)	Mar. 31, 2017
Earnings Per Share [Abstract]
Schedule of Earnings per Share	Following is the reconciliation between the number of weighted-average shares used in the basic and diluted earnings per share calculation: Three Months Ended March 31, Six Months Ended March 31, 2017 2016 2017 2016 Basic weighted-average shares outstanding 57.4 59.4 57.5 59.6 Effect of dilutive securities: Share options — — — — RSE awards 0.3 0.5 0.3 0.5 Total dilutive securities 0.3 0.5 0.3 0.5 Diluted weighted-average shares outstanding 57.7 59.9 57.8 60.1

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
Goodwill and Intangible Assets (Tables)	Mar. 31, 2017
Goodwill and Intangibles [Abstract]
Schedule of Goodwill	The following table sets forth goodwill by segment: Wet Sun and Skin Feminine All Total Balance at October 1, 2016 $ 965.3 $ 178.0 $ 207.4 $ 69.6 $ 1,420.3 Acquisition of Bulldog — 13.3 — — 13.3 Cumulative translation adjustment (6.8 ) 0.4 (0.6 ) — (7.0 ) Balance at March 31, 2017 $ 958.5 $ 191.7 $ 206.8 $ 69.6 $ 1,426.6
Schedule of Amortizable Intangible Assets	Total amortizable intangible assets were as follows: March 31, 2017 September 30, 2016 Gross Accumulated Net Gross Accumulated Net Trade names and brands $ 45.4 $ 12.9 $ 32.5 $ 14.6 $ 12.2 $ 2.4 Technology and patents 77.1 71.5 5.6 76.9 69.8 7.1 Customer related and other 149.4 84.3 65.1 141.8 79.6 62.2 Total amortizable intangible assets $ 271.9 $ 168.7 $ 103.2 $ 233.3 $ 161.6 $ 71.7

Supplemental Balance Sheet In26

Supplemental Balance Sheet Information (Tables)	6 Months Ended
Supplemental Balance Sheet Information (Tables)	Mar. 31, 2017
Supplemental Financial Statement Information [Abstract]
Supplement Balance Sheet Information	March 31, September 30, Inventories Raw materials and supplies $ 56.9 $ 50.8 Work in process 49.6 43.9 Finished products 259.9 214.5 Total inventories $ 366.4 $ 309.2 Other Current Assets Miscellaneous receivables $ 35.8 $ 29.1 Prepaid expenses 62.2 49.0 Value added tax collectible from customers 23.7 22.4 Income taxes receivable 17.0 39.3 Other 4.1 3.4 Total other current assets $ 142.8 $ 143.2 Property, Plant and Equipment Land $ 23.1 $ 27.8 Buildings 141.6 146.0 Machinery and equipment 908.3 913.7 Capitalized software costs 40.5 38.4 Construction in progress 49.4 36.2 Total gross property 1,162.9 1,162.1 Accumulated depreciation (700.9 ) (676.0 ) Total property, plant and equipment, net $ 462.0 $ 486.1 Other Current Liabilities Accrued advertising, sales promotion and allowances $ 50.0 $ 46.8 Accrued trade allowances 28.0 30.1 Accrued salaries, vacations and incentive compensation 33.0 56.0 Income taxes payable 23.5 19.7 Returns reserve 37.2 49.9 Restructuring reserve 12.6 21.9 Value added tax payable 30.8 25.0 Deferred compensation 5.7 26.1 Other 85.3 95.9 Total other current liabilities $ 306.1 $ 371.4 Other Liabilities Pensions and other retirement benefits $ 146.9 $ 154.9 Deferred compensation 54.8 58.6 Other non-current liabilities 60.5 61.3 Total other liabilities $ 262.2 $ 274.8

Debt (Tables)

Debt (Tables)	6 Months Ended
Debt (Tables)	Mar. 31, 2017
Debt [Abstract]
Schedule of Long-term Debt	The detail of long-term debt was as follows: March 31, September 30, Senior notes, fixed interest rate of 4.7%, due 2021, net (1) $ 598.0 $ 597.8 Senior notes, fixed interest rate of 4.7%, due 2022, net (1) (2) 497.2 496.9 U.S. revolving credit facility due 2020 330.0 265.0 Netherlands revolving credit facility due 2017 — 281.8 Term loan, due 2019, net (1) 184.6 184.5 Total long-term debt, including current maturities 1,609.8 1,826.0 Less current portion — 281.8 Total long-term debt $ 1,609.8 $ 1,544.2 (1) At March 31, 2017 , the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.0 , $2.1 and $0.4 , respectively. At September 30, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.2 , $2.3 and $0.5 , respectively. (2) At March 31, 2017 and September 30, 2016, the balance for the senior notes due 2022 is reflected net of discount of $0.7 and $0.8 , respectively.

Retirement Plans (Tables)

Retirement Plans (Tables)	6 Months Ended
Retirement Plans (Tables)	Mar. 31, 2017
Pension and Other Postretirement Benefits [Abstract]
Schedule of Net Periodic Pension and Postretirement Benefit (Credit) Cost	The Company's net periodic pension and postretirement benefit (credit) cost for these plans was as follows: Three Months Ended March 31, Six Months Ended March 31, 2017 2016 2017 2016 Service cost $ 1.9 $ 1.3 $ 3.7 $ 2.6 Interest cost 3.7 5.6 7.5 11.1 Expected return on plan assets (8.0 ) (7.7 ) (15.9 ) (14.6 ) Amortization of unrecognized prior service cost — — — — Recognized net actuarial loss 1.5 1.0 3.0 2.0 Settlement loss recognized — — 0.3 — Net periodic benefit (credit) cost $ (0.9 ) $ 0.2 $ (1.4 ) $ 1.1

Accumulated Other Comprehensi29

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
Accumulated Other Comprehensive Loss (Tables)	Mar. 31, 2017
Accumulated Other Comprehensive (Loss) Income [Abstract]
Schedule of Accumulated Other Comprehensive Loss	The following table presents the changes in accumulated other comprehensive loss ("AOCI"), net of tax, by component: Foreign Pension and Hedging Total Balance at October 1, 2016 $ (68.1 ) $ (126.3 ) $ (2.8 ) $ (197.2 ) OCI before reclassifications (1) (28.7 ) 2.3 3.6 (22.8 ) Reclassifications to earnings — 2.2 0.9 3.1 Balance at March 31, 2017 $ (96.8 ) $ (121.8 ) $ 1.7 $ (216.9 ) Foreign Pension and Hedging Total Balance at October 1, 2015 $ (69.1 ) $ (105.7 ) $ 3.3 $ (171.5 ) OCI before reclassifications (1) 7.3 (7.3 ) (9.4 ) (9.4 ) Reclassifications to earnings — 1.3 3.2 4.5 Balance at March 31, 2016 $ (61.8 ) $ (111.7 ) $ (2.9 ) $ (176.4 ) (1) OCI is defined as other comprehensive income (loss).
Schedule of Reclassifications out of Accumulated Other Comprehensive Loss	The following table presents the reclassifications out of AOCI: For the Three Months Ended For the Six Months Ended March 31, Affected Line Item in the Condensed Consolidated Statements of Earnings Details of AOCI Components 2017 2016 2017 2016 Gains and losses on cash flow hedges Foreign exchange contracts $ 1.7 $ 1.0 $ 1.4 $ 4.6 Other income, net 1.7 1.0 1.4 4.6 Total before tax (0.6 ) (0.3 ) (0.5 ) (1.4 ) Tax expense 1.1 0.7 0.9 3.2 Net of tax Amortization of defined benefit pension and postretirement items Prior service costs — — — — (1) Actuarial losses 1.5 1.0 3.0 2.0 (1) Settlement loss recognized — — 0.3 — (1) 1.5 1.0 3.3 2.0 Total before tax (0.5 ) (0.3 ) (1.1 ) (0.7 ) Tax expense 1.0 0.7 2.2 1.3 Net of tax Total reclassifications for the period $ 2.1 $ 1.4 $ 3.1 $ 4.5 Net of tax (1) These AOCI components are included in the computation of net periodic benefit (credit) cost. See Note 9 of Notes to Condensed Consolidated Financial Statements.

Financial Instruments and Ris30

Financial Instruments and Risk Management (Tables)	6 Months Ended
Financial Instruments and Risk Management (Tables)	Mar. 31, 2017
Financial Instruments and Risk Management [Abstract]
Schedule of Derivative Instruments Designated as Cash Flow Hedges	The following table provides estimated fair values and the amounts of gains and losses on derivative instruments classified as cash flow hedges: At March 31, 2017 For the Three Months Ended For the Six Months Ended Derivatives designated as cash flow hedging relationships Estimated Fair Value, Asset (1) (2) Loss Recognized in OCI Gain Reclassified From OCI into Income (Effective Portion) (3) (4) Gain Recognized in OCI Gain Reclassified From OCI into Income (Effective (3) (4) Foreign currency contracts $ 2.5 $ (3.5 ) $ 1.7 $ 8.2 $ 1.4 At September 30, 2016 For the Three Months Ended For the Six Months Ended Derivatives designated as cash flow hedging relationships Estimated (1) (2) Loss Recognized Gain Reclassified From OCI into Income (Effective Portion) (3) (4) Loss Recognized Gain Reclassified From OCI into Income (Effective (3) (4) Foreign currency contracts $ (4.3 ) $ (5.3 ) $ 1.0 $ (4.5 ) $ 4.6 (1) All derivative assets are presented in Other current assets or Other assets. (2) All derivative liabilities are presented in Other current liabilities or Other liabilities. (3) (Loss) gain reclassified to income was recorded in Other income, net. (4) Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.
Schedule of Derivative Instruments Not Designated as Cash Flow Hedges	The following table provides estimated fair values and the amounts of gains and losses on derivative instruments not classified as cash flow hedges: At March 31, 2017 For the Three Months Ended March 31, 2017 For the Six Months Ended March 31, 2017 Derivatives not designated as cash flow hedging relationships Estimated Fair Value, Asset Loss Recognized in Income (1) Gain Recognized in Income (1) Foreign currency contracts $ (2.0 ) $ (2.2 ) $ 0.4 At September 30, 2016 For the Three Months Ended March 31, 2016 For the Six Months Ended March 31, 2016 Derivatives not designated as cash flow hedging relationships Estimated Fair Value, Liability Loss Recognized in Income (1) Loss Recognized in Income (1) Foreign currency contracts $ (1.3 ) $ (4.3 ) $ (4.3 ) (1) (Loss) gain recognized in income was recorded in Other income, net.
Schedule of Offsetting Assets and Liabilities	The following table provides financial assets and liabilities for balance sheet offsetting: Offsetting of derivative assets At March 31, 2017 At September 30, 2016 Description Balance Sheet location Gross amounts of recognized assets Gross amounts offset in the Balance Sheet Net amounts of assets presented in the Balance Sheet Gross amounts of recognized assets Gross amounts offset in the Balance Sheet Net amounts of assets presented in the Balance Sheet Foreign currency contracts Other current assets, Other assets $ 3.5 $ (0.7 ) $ 2.8 $ 1.7 $ — $ 1.7 Offsetting of derivative liabilities At March 31, 2017 At September 30, 2016 Description Balance Sheet location Gross amounts of recognized liabilities Gross amounts offset in the Balance Sheet Net amounts of liabilities presented in the Balance Sheet Gross amounts of recognized liabilities Gross amounts offset in the Balance Sheet Net amounts of liabilities presented in the Balance Sheet Foreign currency contracts Other current liabilities, Other liabilities $ (2.4 ) $ 0.1 $ (2.3 ) $ (6.2 ) $ 0.2 $ (6.0 )
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis	The following table sets forth the Company's financial assets and liabilities, which are carried at fair value and measured on a recurring basis during the period, all of which are classified as level 2 within the fair value hierarchy: March 31, September 30, Assets (Liabilities) at estimated fair value: Deferred compensation $ (60.1 ) $ (84.5 ) Derivatives - foreign currency contracts 0.5 (5.6 ) Net liabilities at estimated fair value $ (59.6 ) $ (90.1 )

Segment Data (Tables)

Segment Data (Tables)	6 Months Ended
Segment Data (Tables)	Mar. 31, 2017
Segments [Abstract]
Schedule of Segment Sales and Profitability	Segment net sales and profitability are presented below: Three Months Ended March 31, Six Months Ended March 31, 2017 2016 2017 2016 Net Sales Wet Shave $ 342.6 $ 353.4 $ 648.8 $ 669.7 Sun and Skin Care 150.6 132.5 208.2 186.0 Feminine Care 83.2 91.6 172.3 184.1 All Other 34.6 33.7 66.7 66.5 Total net sales $ 611.0 $ 611.2 $ 1,096.0 $ 1,106.3 Segment Profit Wet Shave $ 73.2 $ 77.7 $ 145.2 $ 144.5 Sun and Skin Care 50.9 39.2 51.7 40.9 Feminine Care 1.6 10.5 9.9 28.1 All Other 7.7 8.0 14.6 15.2 Total segment profit 133.4 135.4 221.4 228.7 General corporate and other expenses (23.5 ) (20.3 ) (39.9 ) (38.0 ) Spin costs (1) — (1.7 ) — (9.2 ) Restructuring and related costs (2) (5.6 ) (5.1 ) (12.8 ) (23.6 ) Industrial sale charges — (0.2 ) — (0.2 ) Amortization of intangibles (4.1 ) (3.6 ) (8.1 ) (7.2 ) Interest and other expense, net (10.7 ) (13.2 ) (26.2 ) (28.5 ) Total earnings before income taxes $ 89.5 $ 91.3 $ 134.4 $ 122.0 (1) Includes pre-tax Selling, general and administrative expense of $1.7 and $9.0 , respectively, and pre-tax Cost of products sold of $0.2 for the six months ended March 31, 2016 related to the separation of the Household Products business in July 2015. (2) Includes pre-tax Cost of products sold of $0.1 and $0.4 for the three and six months ended March 31, 2017, respectively, and $0.1 for the three and six months ended March 31, 2016 associated with obsolescence charges related to the exit of certain non-core product lines as a part of restructuring.
Schedule of Supplemental Product Information	Supplemental product information is presented below for net sales: Three Months Ended Six Months Ended 2017 2016 2017 2016 Razors and blades $ 305.6 $ 315.7 $ 576.9 $ 589.8 Tampons, pads and liners 83.2 91.6 172.3 184.1 Sun care products 131.2 114.9 168.9 151.8 Infant care and other 34.6 33.7 66.7 66.5 Shaving gels and creams 37.0 37.7 71.9 79.9 Skin care products 19.4 17.6 39.3 34.2 Total net sales $ 611.0 $ 611.2 $ 1,096.0 $ 1,106.3

Guarantor and Non-Guarantor F32

Guarantor and Non-Guarantor Financial Information (Tables)	6 Months Ended
Guarantor and Non-Guarantor Financial Information (Tables)	Mar. 31, 2017
Guarantor and Non-Guarantor Financial Information [Abstract]
Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended March 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 433.4 $ 275.6 $ (98.0 ) $ 611.0 Cost of products sold — 237.0 162.4 (98.0 ) 301.4 Gross profit — 196.4 113.2 — 309.6 Selling, general and administrative expense — 69.9 34.0 — 103.9 Advertising and sales promotion expense — 52.7 29.8 — 82.5 Research and development expense — 17.3 0.2 — 17.5 Restructuring charges — 2.2 3.3 — 5.5 Interest expense associated with debt 13.3 3.8 0.2 — 17.3 Other income, net — (0.4 ) (6.2 ) — (6.6 ) Intercompany service fees — (8.1 ) 8.1 — — Equity in earnings of subsidiaries (74.1 ) (36.3 ) — 110.4 — Earnings before income taxes 60.8 95.3 43.8 (110.4 ) 89.5 Income tax (benefit) provision (4.9 ) 21.0 7.7 — 23.8 Net earnings $ 65.7 $ 74.3 $ 36.1 $ (110.4 ) $ 65.7 Statement of Comprehensive Income: Net earnings $ 65.7 $ 74.3 $ 36.1 $ (110.4 ) $ 65.7 Other comprehensive income (loss), net of tax 7.2 (16.5 ) 6.7 9.8 7.2 Total comprehensive income $ 72.9 $ 57.8 $ 42.8 $ (100.6 ) $ 72.9 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Six Months Ended March 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 776.3 $ 507.9 $ (188.2 ) $ 1,096.0 Cost of products sold — 441.5 305.1 (188.2 ) 558.4 Gross profit — 334.8 202.8 — 537.6 Selling, general and administrative expense — 128.6 69.1 — 197.7 Advertising and sales promotion expense — 82.9 50.2 — 133.1 Research and development expense — 33.3 0.5 — 33.8 Restructuring charges — 4.9 7.5 — 12.4 Interest expense associated with debt 26.7 7.1 0.9 — 34.7 Other income, net — — (8.5 ) — (8.5 ) Intercompany service fees — (12.5 ) 12.5 — — Equity in earnings of subsidiaries (116.0 ) (57.4 ) — 173.4 — Earnings before income taxes 89.3 147.9 70.6 (173.4 ) 134.4 Income tax (benefit) provision (9.9 ) 31.9 13.2 — 35.2 Net earnings $ 99.2 $ 116.0 $ 57.4 $ (173.4 ) $ 99.2 Statement of Comprehensive Income: Net earnings $ 99.2 $ 116.0 $ 57.4 $ (173.4 ) $ 99.2 Other comprehensive loss, net of tax (19.7 ) (19.7 ) (21.1 ) 40.8 (19.7 ) Total comprehensive income $ 79.5 $ 96.3 $ 36.3 $ (132.6 ) $ 79.5 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Three Months Ended March 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 440.1 $ 289.2 $ (118.1 ) $ 611.2 Cost of products sold — 246.4 171.4 (117.7 ) 300.1 Gross profit — 193.7 117.8 (0.4 ) 311.1 Selling, general and administrative expense 0.8 67.0 31.9 — 99.7 Advertising and sales promotion expense — 56.1 29.0 (0.1 ) 85.0 Research and development expense — 16.3 0.4 — 16.7 Restructuring charges — 3.9 1.1 — 5.0 Industrial sale charges — 0.2 — — 0.2 Interest expense associated with debt 11.3 4.7 1.8 — 17.8 Other income, net — (2.8 ) (1.8 ) — (4.6 ) Intercompany service fees — (3.9 ) 3.9 — — Equity in earnings of subsidiaries (73.7 ) (37.4 ) — 111.1 — Earnings before income taxes 61.6 89.6 51.5 (111.4 ) 91.3 Income tax (benefit) provision (4.5 ) 19.6 10.4 (0.3 ) 25.2 Net earnings $ 66.1 $ 70.0 $ 41.1 $ (111.1 ) $ 66.1 Statement of Comprehensive Income: Net earnings 66.1 70.0 41.1 (111.1 ) 66.1 Other comprehensive income (loss), net of tax 7.0 (9.8 ) 7.3 2.5 7.0 Total comprehensive income $ 73.1 $ 60.2 $ 48.4 $ (108.6 ) $ 73.1 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF EARNINGS AND COMPREHENSIVE INCOME Six Months Ended March 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net sales $ — $ 776.9 $ 558.7 $ (229.3 ) $ 1,106.3 Cost of products sold — 451.3 346.2 (229.8 ) 567.7 Gross profit — 325.6 212.5 0.5 538.6 Selling, general and administrative expense 3.9 127.7 68.5 — 200.1 Advertising and sales promotion expense — 83.6 48.2 (0.2 ) 131.6 Research and development expense — 31.9 0.8 — 32.7 Restructuring charges — 8.6 14.9 — 23.5 Industrial sale charges — 0.2 — — 0.2 Interest expense associated with debt 27.5 4.7 3.3 — 35.5 Other income, net — (5.2 ) (1.8 ) — (7.0 ) Intercompany service fees — (9.4 ) 9.4 — — Equity in earnings of subsidiaries (109.5 ) (49.8 ) — 159.3 — Earnings before income taxes 78.1 133.3 69.2 (158.6 ) 122.0 Income tax (benefit) provision (11.7 ) 29.6 13.6 0.7 32.2 Net earnings $ 89.8 $ 103.7 $ 55.6 $ (159.3 ) $ 89.8 Statement of Comprehensive Income: Net earnings 89.8 103.7 55.6 (159.3 ) 89.8 Other comprehensive loss, net of tax (4.9 ) (11.7 ) (4.2 ) 15.9 (4.9 ) Total comprehensive income $ 84.9 $ 92.0 $ 51.4 $ (143.4 ) $ 84.9
Schedule of Condensed Consolidating Balance Sheets	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS March 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 14.9 $ 388.0 $ — $ 402.9 Trade receivables, net — 164.9 146.1 — 311.0 Inventories — 226.8 139.6 — 366.4 Other current assets — 41.2 101.6 — 142.8 Total current assets — 447.8 775.3 — 1,223.1 Investment in subsidiaries 3,580.0 1,194.4 — (4,774.4 ) — Intercompany receivables, net (1) — 556.4 59.9 (616.3 ) — Intercompany notes receivable (1) — 1.9 — (1.9 ) — Property, plant and equipment, net — 332.6 129.4 — 462.0 Goodwill — 1,061.8 364.8 — 1,426.6 Other intangible assets, net — 1,227.9 163.3 — 1,391.2 Other assets 1.9 0.1 25.7 — 27.7 Total assets $ 3,581.9 $ 4,822.9 $ 1,518.4 $ (5,392.6 ) $ 4,530.6 Liabilities and Shareholders' Equity Current liabilities $ 20.9 $ 274.0 $ 262.5 $ — $ 557.4 Intercompany payables, net (1) 616.3 — — (616.3 ) — Intercompany notes payable (1) — — 1.9 (1.9 ) — Long-term debt 1,094.8 515.0 — — 1,609.8 Deferred income tax liabilities — 227.6 24.1 — 251.7 Other liabilities 0.4 226.3 35.5 — 262.2 Total liabilities 1,732.4 1,242.9 324.0 (618.2 ) 2,681.1 Total shareholders' equity 1,849.5 3,580.0 1,194.4 (4,774.4 ) 1,849.5 Total liabilities and shareholders' equity $ 3,581.9 $ 4,822.9 $ 1,518.4 $ (5,392.6 ) $ 4,530.6 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business. EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING BALANCE SHEETS September 30, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Assets Current assets Cash and cash equivalents $ — $ 5.8 $ 733.1 $ — $ 738.9 Trade receivables, net — 108.9 151.8 — 260.7 Inventories — 187.7 121.5 — 309.2 Other current assets — 43.7 99.5 — 143.2 Total current assets — 346.1 1,105.9 — 1,452.0 Investment in subsidiaries 3,483.7 825.0 — (4,308.7 ) — Intercompany receivables, net (1) — 487.6 53.5 (541.1 ) — Intercompany notes receivable (1) — 1.9 — (1.9 ) — Property, plant and equipment, net — 343.8 142.3 — 486.1 Goodwill — 1,061.9 358.4 — 1,420.3 Other intangible assets, net — 1,235.1 150.0 — 1,385.1 Other assets 2.0 0.1 25.9 — 28.0 Total assets $ 3,485.7 $ 4,301.5 $ 1,836.0 $ (4,851.7 ) $ 4,771.5 Liabilities and Shareholders' Equity Current liabilities $ 21.4 $ 288.4 $ 558.4 $ — $ 868.2 Intercompany payables, net (1) 541.1 — — (541.1 ) — Intercompany notes payable (1) — — 1.9 (1.9 ) — Long-term debt 1,094.2 450.0 — — 1,544.2 Deferred income tax liabilities — 232.4 22.9 — 255.3 Other liabilities — 236.3 38.5 — 274.8 Total liabilities 1,656.7 1,207.1 621.7 (543.0 ) 2,942.5 Total shareholders' equity 1,829.0 3,094.4 1,214.3 (4,308.7 ) 1,829.0 Total liabilities and shareholders' equity $ 3,485.7 $ 4,301.5 $ 1,836.0 $ (4,851.7 ) $ 4,771.5 (1) Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.
Schedule of Condensed Consolidating Statements of Cash Flows	EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Six Months Ended March 31, 2017 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from (used by) operations $ 56.5 $ (36.5 ) $ 49.6 $ (70.0 ) $ (0.4 ) Cash Flow from Investing Activities Capital expenditures — (25.0 ) (5.4 ) — (30.4 ) Acquisitions, net of cash acquired — — (34.0 ) — (34.0 ) Proceeds from sale of assets — 5.9 — — 5.9 Net cash used by investing activities — (19.1 ) (39.4 ) — (58.5 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 181.0 — — 181.0 Cash payments on debt with original maturities greater than 90 days — (116.0 ) (277.0 ) — (393.0 ) Net (decrease) increase in debt with original maturities of 90 days or less — (0.3 ) 1.5 — 1.2 Common shares purchased (58.5 ) — — — (58.5 ) Intercompany dividend — — (70.0 ) 70.0 — Other, net 2.0 — — — 2.0 Net cash (used by) from financing activities (56.5 ) 64.7 (345.5 ) 70.0 (267.3 ) Effect of exchange rate changes on cash — — (9.8 ) — (9.8 ) Net increase (decrease) in cash and cash equivalents — 9.1 (345.1 ) — (336.0 ) Cash and cash equivalents, beginning of period — 5.8 733.1 — 738.9 Cash and cash equivalents, end of period $ — $ 14.9 $ 388.0 $ — $ 402.9 EDGEWELL PERSONAL CARE COMPANY CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS Six Months Ended March 31, 2016 Parent Company Guarantors Non-Guarantors Eliminations Total Net cash flow from (used by) operations $ 78.9 $ (74.5 ) $ (77.0 ) $ — $ (72.6 ) Cash Flow from Investing Activities Capital expenditures — (30.7 ) (3.8 ) — (34.5 ) Payment for equity contributions — (0.5 ) — 0.5 — Net cash used by investing activities — (31.2 ) (3.8 ) 0.5 (34.5 ) Cash Flow from Financing Activities Cash proceeds from debt with original maturities greater than 90 days — 391.0 4.3 — 395.3 Cash payments on debt with original maturities greater than 90 days — (261.0 ) — — (261.0 ) Net decrease in debt with original maturities of 90 days or less — (5.3 ) (0.3 ) — (5.6 ) Common shares purchased (78.9 ) — — — (78.9 ) Proceeds for equity contributions — — 0.5 (0.5 ) — Net cash (used by) from financing activities (78.9 ) 124.7 4.5 (0.5 ) 49.8 Effect of exchange rate changes on cash — — 5.7 — 5.7 Net increase (decrease) in cash and cash equivalents — 19.0 (70.6 ) — (51.6 ) Cash and cash equivalents, beginning of period — 2.9 709.2 — 712.1 Cash and cash equivalents, end of period $ — $ 21.9 $ 638.6 $ — $ 660.5

Background and Basis of Prese33

Background and Basis of Presentation (Details) $ in Millions	Mar. 31, 2017USD ($)brandscountry
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of brands \| brands	25
Number of countries in which Edgewell operates \| country	50
ASU 2017-07
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Expected impact of adopting ASU 2017-07, Cost of products sold	$ 3.3
Expected impact of adopting ASU 2017-07, SG&A	1.2
Expected impact of adopting ASU 2017-07, Other income, net	$ 4.5

Acquisition (Details)

Acquisition (Details) £ in Millions, $ in Millions	Oct. 31, 2016USD ($)	Oct. 31, 2016GBP (£)	Mar. 31, 2017USD ($)	Sep. 30, 2016USD ($)
Business Acquisition [Line Items]
Goodwill			$ 1,426.6	$ 1,420.3
Weighted-average useful life of acquired finite-lived intangible assets	14 years 5 months	14 years 5 months
Bulldog
Business Acquisition [Line Items]
Purchase price, net of cash acquired	$ 34	£ 27.8
Cash	1.2
Inventory	2.5
Other assets	5.9
Goodwill	13.3
Other intangible assets	18
Liabilities	(5.7)
Net assets acquired	$ 35.2

Restructuring Charges (Narrativ

Restructuring Charges (Narrative) (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended		53 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Sep. 30, 2016	Sep. 30, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs	[1]	$ 5.6	$ 5.1	$ 12.8	$ 23.6
Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		11.6		11.6		$ 11.6	$ 16.7	$ 13.7
Restructuring charges incurred to date						152.6
Minimum \| Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges expected, fiscal 2017		25		25		25
Maximum \| Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges expected, fiscal 2017		28		28		28
Spinoff \| New Energizer \| Spin Restructuring
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		1		1		$ 1	$ 5.2
Obsolescence \| Cost of products sold \| Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring and related costs		$ 0.1	$ 0.1	$ 0.4	$ 0.1

[1]	Includes pre-tax Cost of products sold of $0.1 and $0.4 for the three and six months ended March 31, 2017, respectively, and $0.1 for the three and six months ended March 31, 2016 associated with obsolescence charges related to the exit of certain non-core product lines as a part of restructuring.

Restructuring Charges (Schedule

Restructuring Charges (Schedule of Charges Related to Restructuring Activities) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 5.5	$ 5	$ 12.4	$ 23.5
Restructuring Plan
Restructuring Cost and Reserve [Line Items]
Restructuring charges	5.5	5	12.4	23.5
Restructuring Plan \| Severance and related benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1.2	0.2	3.1	13.8
Restructuring Plan \| Asset impairment and accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1.1	0.5	2.8	1.2
Restructuring Plan \| Consulting, program management and other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	3.2	4.3	6.5	8.5
Restructuring Plan \| Wet Shave
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2.5	(0.1)	4.6	11.1
Restructuring Plan \| Wet Shave \| Severance and related benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.3	(1.4)	0.7	9.1
Restructuring Plan \| Wet Shave \| Asset impairment and accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0	0	0
Restructuring Plan \| Wet Shave \| Consulting, program management and other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2.2	1.3	3.9	2
Restructuring Plan \| Sun and Skin Care
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.1	0.3	0.1	0.3
Restructuring Plan \| Sun and Skin Care \| Severance and related benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0.2	0	0.2
Restructuring Plan \| Sun and Skin Care \| Asset impairment and accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0	0	0	0
Restructuring Plan \| Sun and Skin Care \| Consulting, program management and other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.1	0.1	0.1	0.1
Restructuring Plan \| Feminine Care
Restructuring Cost and Reserve [Line Items]
Restructuring charges	2.9	4.8	7.7	12.1
Restructuring Plan \| Feminine Care \| Severance and related benefit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	0.9	1.4	2.4	4.5
Restructuring Plan \| Feminine Care \| Asset impairment and accelerated depreciation
Restructuring Cost and Reserve [Line Items]
Restructuring charges	1.1	0.5	2.8	1.2
Restructuring Plan \| Feminine Care \| Consulting, program management and other exit costs
Restructuring Cost and Reserve [Line Items]
Restructuring charges	$ 0.9	$ 2.9	$ 2.5	$ 6.4

Restructuring Charges (Schedu37

Restructuring Charges (Schedule of Restructuring Activities and Related Accruals) (Details) - Restructuring Plan - USD ($) $ in Millions	6 Months Ended		12 Months Ended
	Mar. 31, 2017		Sep. 30, 2016
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 16.7		$ 13.7
Charge to Income	12.4		37
Other	(0.6)	[1]	0.6	[2]
Utilized - Cash Payments	(14.1)		(30.7)
Utilized - Non-Cash	(2.8)		(3.9)
Ending Balance	11.6		16.7
Severance and termination related costs
Restructuring Reserve [Roll Forward]
Beginning Balance	16.7		13.7
Charge to Income	3.1		17
Other	(0.6)	[1]	0.6	[2]
Utilized - Cash Payments	(7.6)		(14.6)
Utilized - Non-Cash	0		0
Ending Balance	11.6		16.7
Asset impairment and accelerated depreciation
Restructuring Reserve [Roll Forward]
Beginning Balance	0		0
Charge to Income	2.8		3.9
Other	0	[1]	0	[2]
Utilized - Cash Payments	0		0
Utilized - Non-Cash	(2.8)		(3.9)
Ending Balance	0		0
Other related costs
Restructuring Reserve [Roll Forward]
Beginning Balance	0		0
Charge to Income	6.5		16.1
Other	0	[1]	0	[2]
Utilized - Cash Payments	(6.5)		(16.1)
Utilized - Non-Cash	0		0
Ending Balance	$ 0		$ 0

[1]	Includes the impact of currency translation.
[2]	Includes the impact of currency translation.

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Income Taxes [Abstract]
Income tax provision	$ 23.8	$ 25.2	$ 35.2	$ 32.2
Earnings before income taxes	$ 89.5	$ 91.3	$ 134.4	$ 122
Effective tax rate	26.60%	27.60%	26.20%	26.40%

Earnings per Share (Schedule of

Earnings per Share (Schedule of Earnings per Share) (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Earnings Per Share [Abstract]
Basic weighted-average shares outstanding (in shares)	57.4	59.4	57.5	59.6
Effect of dilutive securities, share options (in shares)	0	0	0	0
Effect of dilutive securities, RSE awards (in shares)	0.3	0.5	0.3	0.5
Total dilutive securities (in shares)	0.3	0.5	0.3	0.5
Diluted weighted-average shares outstanding (in shares)	57.7	59.9	57.8	60.1

Earnings per Share (Narrative)

Earnings per Share (Narrative) (Details) - shares shares in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Share options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)	0.6	0.4	0.6	0.4
RSE awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive awards excluded from the calculation of diluted weighted-average shares outstanding (in shares)		0.1		0.1

Goodwill and Intangible Asset41

Goodwill and Intangible Assets (Schedule of Goodwill) (Details) $ in Millions	6 Months Ended
	Mar. 31, 2017USD ($)
Goodwill [Roll Forward]
Beginning balance	$ 1,420.3
Cumulative translation adjustment	(7)
Ending balance	1,426.6
Wet Shave
Goodwill [Roll Forward]
Beginning balance	965.3
Cumulative translation adjustment	(6.8)
Ending balance	958.5
Sun and Skin Care
Goodwill [Roll Forward]
Beginning balance	178
Cumulative translation adjustment	0.4
Ending balance	191.7
Feminine Care
Goodwill [Roll Forward]
Beginning balance	207.4
Cumulative translation adjustment	(0.6)
Ending balance	206.8
All Other
Goodwill [Roll Forward]
Beginning balance	69.6
Cumulative translation adjustment	0
Ending balance	69.6
Bulldog
Goodwill [Roll Forward]
Acquisition of Bulldog	13.3
Bulldog \| Wet Shave
Goodwill [Roll Forward]
Acquisition of Bulldog	0
Bulldog \| Sun and Skin Care
Goodwill [Roll Forward]
Acquisition of Bulldog	13.3
Bulldog \| Feminine Care
Goodwill [Roll Forward]
Acquisition of Bulldog	0
Bulldog \| All Other
Goodwill [Roll Forward]
Acquisition of Bulldog	$ 0

Goodwill and Intangible Asset42

Goodwill and Intangible Assets (Schedule of Amortizable Intangible Assets) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Sep. 30, 2016
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	$ 271.9		$ 271.9		$ 233.3
Amortizable intangible assets, accumulated amortization	168.7		168.7		161.6
Amortizable intangible assets, net	103.2		103.2		71.7
Amortization of intangibles	4.1	$ 3.6	8.1	$ 7.2
Amortizable intangible assets, amortization expense, remainder of 2017	8.1		8.1
Amortizable intangible assets, amortization expense, fiscal 2018	8.9		8.9
Amortizable intangible assets, amortization expense, fiscal 2019	7.6		7.6
Amortizable intangible assets, amortization expense, fiscal 2020	6.9		6.9
Amortizable intangible assets, amortization expense, fiscal 2021	6.3		6.3
Amortizable intangible assets, amortization expense, fiscal 2022	6.2		6.2
Amortizable intangible assets, amortization expense, thereafter	59.2		59.2
Trade names and brands
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	45.4		45.4		14.6
Amortizable intangible assets, accumulated amortization	12.9		12.9		12.2
Amortizable intangible assets, net	32.5		32.5		2.4
Technology and patents
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	77.1		77.1		76.9
Amortizable intangible assets, accumulated amortization	71.5		71.5		69.8
Amortizable intangible assets, net	5.6		5.6		7.1
Customer related and other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, gross carrying amount	149.4		149.4		141.8
Amortizable intangible assets, accumulated amortization	84.3		84.3		79.6
Amortizable intangible assets, net	65.1		65.1		$ 62.2
Skintimate brand name
Finite-Lived Intangible Assets [Line Items]
Amortization of intangibles	$ 0.4		$ 0.8
Useful life assigned to Skintimate brand name			20 years
Bulldog
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets acquired during period			$ 8.9

Goodwill and Intangible Asset43

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Mar. 31, 2017	Sep. 30, 2016	Sep. 30, 2015
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	$ 1,288
Indefinite-lived intangible assets, decrease	(25.4)
Wet Shave
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	224.1
Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	500.5
Feminine Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	299.9
All Other
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	263.5
Skintimate brand name
Indefinite-lived Intangible Assets [Line Items]
Impairment charge		$ 6.5	$ 29.6
Skintimate brand name \| Wet Shave
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets, decrease due to Skintimate conversion to amortizable intangible asset	(30.9)
Bulldog \| Sun and Skin Care
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived intangible assets acquired during the period	$ 9.1

Supplemental Balance Sheet In44

Supplemental Balance Sheet Information (Details) - USD ($) $ in Millions	Mar. 31, 2017	Sep. 30, 2016
Inventories
Raw materials and supplies	$ 56.9	$ 50.8
Work in process	49.6	43.9
Finished products	259.9	214.5
Inventories	366.4	309.2
Other Current Assets
Miscellaneous receivables	35.8	29.1
Prepaid expenses	62.2	49
Value added tax collectible from customers	23.7	22.4
Income taxes receivable	17	39.3
Other	4.1	3.4
Other current assets	142.8	143.2
Property, Plant and Equipment
Land	23.1	27.8
Buildings	141.6	146
Machinery and equipment	908.3	913.7
Capitalized software costs	40.5	38.4
Construction in progress	49.4	36.2
Total gross property	1,162.9	1,162.1
Accumulated depreciation	(700.9)	(676)
Property, plant and equipment, net	462	486.1
Other Current Liabilities
Accrued advertising, sales promotion and allowances	50	46.8
Accrued trade allowances	28	30.1
Accrued salaries, vacations and incentive compensation	33	56
Income taxes payable	23.5	19.7
Returns reserve	37.2	49.9
Restructuring reserve	12.6	21.9
Value added tax payable	30.8	25
Deferred compensation	5.7	26.1
Other	85.3	95.9
Other current liabilities	306.1	371.4
Other Liabilities
Pensions and other retirement benefits	146.9	154.9
Deferred compensation	54.8	58.6
Other non-current liabilities	60.5	61.3
Other liabilities	$ 262.2	$ 274.8

Debt (Details)

Debt (Details) € in Millions, $ in Millions		Oct. 20, 2016USD ($)	Oct. 20, 2016EUR (€)	Mar. 31, 2017USD ($)	Mar. 13, 2017USD ($)	Sep. 30, 2016USD ($)	Apr. 26, 2016USD ($)
Debt Instrument [Line Items]
Total long-term debt, including current maturities				$ 1,609.8		$ 1,826
Current maturities of long-term debt				0		281.8
Long-term debt				1,609.8		1,544.2
Notes payable				19.7		18.5
Senior notes \| Senior notes due 2021
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1]			598		597.8
Unamortized debt issuance costs				2		2.2
Senior notes \| Senior notes due 2022
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1],[2]			497.2		496.9
Unamortized debt issuance costs				2.1		2.3
Unamortized discount				0.7		0.8
Domestic line of credit \| US revolving credit facility
Debt Instrument [Line Items]
Total long-term debt, including current maturities				330		265
Increase in revolving credit facility capacity					$ 75
Revolving credit facility maximum borrowing capacity					725		$ 650
Allowable amount of receivables sales facilities under revolving credit agreement					$ 150
Foreign line of credit \| Netherlands revolving credit facility
Debt Instrument [Line Items]
Total long-term debt, including current maturities				0		281.8
Debt repayment, revolving credit facility		$ 277	€ 251.3
Loans payable \| Term loan
Debt Instrument [Line Items]
Total long-term debt, including current maturities	[1]			184.6		184.5
Unamortized debt issuance costs				$ 0.4		$ 0.5

[1]	At March 31, 2017, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.0, $2.1 and $0.4, respectively. At September 30, 2016, the balance for the senior notes due 2021, the senior notes due 2022 and the term loan are reflected net of debt issuance costs of $2.2, $2.3 and $0.5, respectively.
[2]	At March 31, 2017 and September 30, 2016, the balance for the senior notes due 2022 is reflected net of discount of $0.7 and $0.8, respectively.

Retirement Plans (Details)

Retirement Plans (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Retirement Plans (Details) - USD ($) $ in Millions	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Pension and Other Postretirement Benefits [Abstract]
Service cost	$ 1.9	$ 1.3	$ 3.7	$ 2.6
Interest cost	3.7	5.6	7.5	11.1
Expected return on plan assets	(8)	(7.7)	(15.9)	(14.6)
Amortization of unrecognized prior service cost	0	0	0	0
Recognized net actuarial loss	1.5	1	3	2
Settlement loss recognized	0	0	0.3	0
Net periodic benefit (credit) cost	(0.9)	$ 0.2	(1.4)	$ 1.1
Expected decrease in interest and service cost for fiscal 2017	$ 4		$ 4

Shareholders' Equity (Details)

Shareholders' Equity (Details) - USD ($) shares in Millions, $ in Millions	6 Months Ended
	Mar. 31, 2017	May 31, 2015
Shareholders' Equity [Abstract]
Shares authorized for repurchase (in shares)		10
Repurchase of shares (in shares)	0.8
Repurchase of shares (in usd)	$ 58.5
Remaining shares authorized for repurchase (in shares)	4.7
Shares withheld for taxes on share based compensation (in shares)	0.2
Cash dividends paid related to RSE award vests	$ 0.8

Accumulated Other Comprehensi48

Accumulated Other Comprehensive Loss (Schedule of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		6 Months Ended
		Mar. 31, 2017	Mar. 31, 2016
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		$ (197.2)	$ (171.5)
OCI before reclassifications	[1]	(22.8)	(9.4)
Reclassifications to earnings		3.1	4.5
Ending balance		(216.9)	(176.4)
Foreign Currency Translation Adjustments
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(68.1)	(69.1)
OCI before reclassifications	[1]	(28.7)	7.3
Reclassifications to earnings		0	0
Ending balance		(96.8)	(61.8)
Pension and Post-retirement Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(126.3)	(105.7)
OCI before reclassifications	[1]	2.3	(7.3)
Reclassifications to earnings		2.2	1.3
Ending balance		(121.8)	(111.7)
Hedging Activity
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance		(2.8)	3.3
OCI before reclassifications	[1]	3.6	(9.4)
Reclassifications to earnings		0.9	3.2
Ending balance		$ 1.7	$ (2.9)

[1]	OCI is defined as other comprehensive income (loss).

Accumulated Other Comprehensi49

Accumulated Other Comprehensive Loss (Schedule of Reclassifications out of Accumulated Other Comprehensive Loss) (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Reclassifications to earnings				$ (3.1)	$ (4.5)
Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		$ 1.7	$ 1	1.4	4.6
Gains and losses on cash flow hedges, foreign exchange contracts, tax		(0.6)	(0.3)	(0.5)	(1.4)
Gains and losses on cash flow hedges, foreign exchange contracts, after tax		1.1	0.7	0.9	3.2
Amortization of defined benefit pension and postretirement items, prior service cost, before tax	[1]	0	0	0	0
Amortization of defined benefit pension and postretirement items, actuarial losses, before tax	[1]	1.5	1	3	2
Amortization of defined benefit pension and postretirement items, settlement loss recognized, before tax	[1]	0	0	0.3	0
Amortization of defined benefit pension and postretirement items, before tax		1.5	1	3.3	2
Amortization of defined benefit pension and postretirement items, tax		(0.5)	(0.3)	(1.1)	(0.7)
Amortization of defined benefit pension and postretirement items, after tax		1	0.7	2.2	1.3
Reclassifications to earnings		2.1	1.4	3.1	4.5
Other income, net \| Reclassification out of Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Gains and losses on cash flow hedges, foreign exchange contracts, before tax		$ 1.7	$ 1	$ 1.4	$ 4.6

[1]	These AOCI components are included in the computation of net periodic benefit (credit) cost. See Note 9 of Notes to Condensed Consolidated Financial Statements

Financial Instruments and Ris50

Financial Instruments and Risk Management (Narrative) (Details) $ in Millions		3 Months Ended		6 Months Ended
		Mar. 31, 2017USD ($)contracts	Mar. 31, 2016USD ($)	Mar. 31, 2017USD ($)contracts	Mar. 31, 2016USD ($)	Sep. 30, 2016USD ($)
Derivative [Line Items]
Carrying value of long-term debt		$ 1,609.8		$ 1,609.8		$ 1,826
Variable rate
Derivative [Line Items]
Variable rate debt outstanding		514.6		514.6
Not designated as hedge \| FX contract
Derivative [Line Items]
Estimated fair value of derivative		$ (2)		$ (2)		(1.3)
Open foreign currency contracts \| contracts		5		5
Notional value		$ 85.3		$ 85.3
Cash flow hedge \| Designated as hedge \| FX contract
Derivative [Line Items]
Estimated fair value of derivative	[1],[2]	$ 2.5		$ 2.5		(4.3)
Open foreign currency contracts \| contracts		69		69
Notional value		$ 131.5		$ 131.5
Other income, net \| Not designated as hedge \| FX contract
Derivative [Line Items]
Change in estimate fair value of foreign currency contracts	[3]	(2.2)	$ (4.3)	0.4	$ (4.3)
Fixed rate
Derivative [Line Items]
Fair value of long-term debt		1,136.9		1,136.9		1,106.2
Carrying value of long-term debt		1,095.2		1,095.2		1,094.7
Term loan
Derivative [Line Items]
Fair value of long-term debt		$ 185		$ 185		$ 185

[1]	All derivative assets are presented in Other current assets or Other assets.
[2]	All derivative liabilities are presented in Other current liabilities or Other liabilities.
[3]	(Loss) gain recognized in income was recorded in Other income, net.

Financial Instruments and Ris51

Financial Instruments and Risk Management (Schedule of Derivative Instruments Designated as Cash Flow Hedges) (Details) - Designated as hedge - Cash flow hedge - FX contract - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Sep. 30, 2016
Derivative [Line Items]
Estimated fair value of derivative	[1],[2]	$ 2.5		$ 2.5		$ (4.3)
(Loss) gain recognized in OCI		(3.5)	$ (5.3)	8.2	$ (4.5)
Other income, net
Derivative [Line Items]
Gain reclassified from OCI into income	[3],[4]	$ 1.7	$ 1	$ 1.4	$ 4.6

[1]	All derivative assets are presented in Other current assets or Other assets.
[2]	All derivative liabilities are presented in Other current liabilities or Other liabilities.
[3]	(Loss) gain reclassified to income was recorded in Other income, net.
[4]	Each of these derivative instruments had a high correlation to the underlying exposure being hedged for the periods indicated and had been deemed highly effective in offsetting associated risk.

Financial Instruments and Ris52

Financial Instruments and Risk Management (Schedule of Derivative Instruments Not Designated as Cash Flow Hedges) (Details) - Not designated as hedge - FX contract - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016	Sep. 30, 2016
Derivative [Line Items]
Estimated fair value of derivative		$ (2)		$ (2)		$ (1.3)
Other income, net
Derivative [Line Items]
(Loss) gain recognized in income	[1]	$ (2.2)	$ (4.3)	$ 0.4	$ (4.3)

[1]	(Loss) gain recognized in income was recorded in Other income, net.

Financial Instruments and Ris53

Financial Instruments and Risk Management (Schedule of Offsetting Assets and Liabilities) (Details) - FX contract - USD ($) $ in Millions	Mar. 31, 2017	Sep. 30, 2016
Other current assets
Derivative [Line Items]
Gross amounts of recognized assets	$ 3.5	$ 1.7
Gross amounts of recognized assets offset in the Balance Sheet	(0.7)	0
Net amounts of assets presented in the Balance Sheet	2.8	1.7
Other current liabilities
Derivative [Line Items]
Gross amounts of recognized liabilities	(2.4)	(6.2)
Gross amounts of recognized liabilities offset in the Balance Sheet	0.1	0.2
Net amounts of liabilities presented in the Balance Sheet	$ (2.3)	$ (6)

Financial Instruments and Ris54

Financial Instruments and Risk Management (Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis) (Details) - Recurring fair value measurement - Level 2 - USD ($) $ in Millions	Mar. 31, 2017	Sep. 30, 2016
Derivative [Line Items]
Deferred compensation	$ (60.1)	$ (84.5)
Net liabilities at estimated fair value	(59.6)	(90.1)
FX contract
Derivative [Line Items]
Derivatives - foreign currency contracts	$ 0.5	$ (5.6)

Segment Data (Schedule of Segme

Segment Data (Schedule of Segment Sales and Profitability) (Details) - USD ($) $ in Millions		3 Months Ended		6 Months Ended
		Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Segment Reporting Information [Line Items]
Net sales		$ 611	$ 611.2	$ 1,096	$ 1,106.3
Restructuring and related costs	[1]	(5.6)	(5.1)	(12.8)	(23.6)
Industrial sale charges		0	(0.2)	0	(0.2)
Amortization of intangibles		(4.1)	(3.6)	(8.1)	(7.2)
Interest and other expense, net		(10.7)	(13.2)	(26.2)	(28.5)
Earnings before income taxes		89.5	91.3	134.4	122
Wet Shave
Segment Reporting Information [Line Items]
Net sales		342.6	353.4	648.8	669.7
Segment profit		73.2	77.7	145.2	144.5
Sun and Skin Care
Segment Reporting Information [Line Items]
Net sales		150.6	132.5	208.2	186
Segment profit		50.9	39.2	51.7	40.9
Feminine Care
Segment Reporting Information [Line Items]
Net sales		83.2	91.6	172.3	184.1
Segment profit		1.6	10.5	9.9	28.1
All Other
Segment Reporting Information [Line Items]
Net sales		34.6	33.7	66.7	66.5
Segment profit		7.7	8	14.6	15.2
Operating Segments
Segment Reporting Information [Line Items]
Segment profit		133.4	135.4	221.4	228.7
Corporate
Segment Reporting Information [Line Items]
General corporate and other expenses		(23.5)	(20.3)	(39.9)	(38)
Spinoff \| New Energizer
Segment Reporting Information [Line Items]
Spin costs	[2]	0	(1.7)	0	(9.2)
Spinoff \| Selling, general and administrative expense \| New Energizer
Segment Reporting Information [Line Items]
Spin costs			(1.7)		(9)	[2]
Spinoff \| Cost of products sold \| New Energizer
Segment Reporting Information [Line Items]
Spin costs					(0.2)
Obsolescence \| Restructuring Plan \| Cost of products sold
Segment Reporting Information [Line Items]
Restructuring and related costs		$ (0.1)	$ (0.1)	$ (0.4)	$ (0.1)

[1]	Includes pre-tax Cost of products sold of $0.1 and $0.4 for the three and six months ended March 31, 2017, respectively, and $0.1 for the three and six months ended March 31, 2016 associated with obsolescence charges related to the exit of certain non-core product lines as a part of restructuring.
[2]	Includes pre-tax Selling, general and administrative expense of $1.7 and $9.0, respectively, and pre-tax Cost of products sold of $0.2 for the six months ended March 31, 2016 related to the separation of the Household Products business in July 2015.

Segment Data (Schedule of Suppl

Segment Data (Schedule of Supplemental Product Information) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Revenue from External Customer [Line Items]
Net sales	$ 611	$ 611.2	$ 1,096	$ 1,106.3
Razors and blades
Revenue from External Customer [Line Items]
Net sales	305.6	315.7	576.9	589.8
Tampons, pads and liners
Revenue from External Customer [Line Items]
Net sales	83.2	91.6	172.3	184.1
Sun care products
Revenue from External Customer [Line Items]
Net sales	131.2	114.9	168.9	151.8
Infant care and other
Revenue from External Customer [Line Items]
Net sales	34.6	33.7	66.7	66.5
Shaving gels and creams
Revenue from External Customer [Line Items]
Net sales	37	37.7	71.9	79.9
Skin care products
Revenue from External Customer [Line Items]
Net sales	$ 19.4	$ 17.6	$ 39.3	$ 34.2

Guarantor and Non-Guarantor F57

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Earnings and Comprehensive Income) (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Income Statement [Abstract]
Net sales	$ 611	$ 611.2	$ 1,096	$ 1,106.3
Cost of products sold	301.4	300.1	558.4	567.7
Gross profit	309.6	311.1	537.6	538.6
Selling, general and administrative expense	103.9	99.7	197.7	200.1
Advertising and sales promotion expense	82.5	85	133.1	131.6
Research and development expense	17.5	16.7	33.8	32.7
Restructuring charges	5.5	5	12.4	23.5
Industrial sale charges	0	0.2	0	0.2
Interest expense associated with debt	17.3	17.8	34.7	35.5
Other income, net	(6.6)	(4.6)	(8.5)	(7)
Intercompany service fees	0	0	0	0
Equity in earnings of subsidiaries	0	0	0	0
Earnings before income taxes	89.5	91.3	134.4	122
Income tax (benefit) provision	23.8	25.2	35.2	32.2
Net earnings	65.7	66.1	99.2	89.8
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	65.7	66.1	99.2	89.8
Other comprehensive income (loss), net of tax	7.2	7	(19.7)	(4.9)
Total comprehensive income	72.9	73.1	79.5	84.9
Eliminations
Income Statement [Abstract]
Net sales	(98)	(118.1)	(188.2)	(229.3)
Cost of products sold	(98)	(117.7)	(188.2)	(229.8)
Gross profit	0	(0.4)	0	0.5
Selling, general and administrative expense	0	0	0	0
Advertising and sales promotion expense	0	(0.1)	0	(0.2)
Research and development expense	0	0	0	0
Restructuring charges	0	0	0	0
Industrial sale charges		0		0
Interest expense associated with debt	0	0	0	0
Other income, net	0	0	0	0
Intercompany service fees	0	0	0	0
Equity in earnings of subsidiaries	110.4	111.1	173.4	159.3
Earnings before income taxes	(110.4)	(111.4)	(173.4)	(158.6)
Income tax (benefit) provision	0	(0.3)	0	0.7
Net earnings	(110.4)	(111.1)	(173.4)	(159.3)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	(110.4)	(111.1)	(173.4)	(159.3)
Other comprehensive income (loss), net of tax	9.8	2.5	40.8	15.9
Total comprehensive income	(100.6)	(108.6)	(132.6)	(143.4)
Parent
Income Statement [Abstract]
Net sales	0	0	0	0
Cost of products sold	0	0	0	0
Gross profit	0	0	0	0
Selling, general and administrative expense	0	0.8	0	3.9
Advertising and sales promotion expense	0	0	0	0
Research and development expense	0	0	0	0
Restructuring charges	0	0	0	0
Industrial sale charges		0		0
Interest expense associated with debt	13.3	11.3	26.7	27.5
Other income, net	0	0	0	0
Intercompany service fees	0	0	0	0
Equity in earnings of subsidiaries	(74.1)	(73.7)	(116)	(109.5)
Earnings before income taxes	60.8	61.6	89.3	78.1
Income tax (benefit) provision	(4.9)	(4.5)	(9.9)	(11.7)
Net earnings	65.7	66.1	99.2	89.8
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	65.7	66.1	99.2	89.8
Other comprehensive income (loss), net of tax	7.2	7	(19.7)	(4.9)
Total comprehensive income	72.9	73.1	79.5	84.9
Guarantors
Income Statement [Abstract]
Net sales	433.4	440.1	776.3	776.9
Cost of products sold	237	246.4	441.5	451.3
Gross profit	196.4	193.7	334.8	325.6
Selling, general and administrative expense	69.9	67	128.6	127.7
Advertising and sales promotion expense	52.7	56.1	82.9	83.6
Research and development expense	17.3	16.3	33.3	31.9
Restructuring charges	2.2	3.9	4.9	8.6
Industrial sale charges		0.2		0.2
Interest expense associated with debt	3.8	4.7	7.1	4.7
Other income, net	(0.4)	(2.8)	0	(5.2)
Intercompany service fees	(8.1)	(3.9)	(12.5)	(9.4)
Equity in earnings of subsidiaries	(36.3)	(37.4)	(57.4)	(49.8)
Earnings before income taxes	95.3	89.6	147.9	133.3
Income tax (benefit) provision	21	19.6	31.9	29.6
Net earnings	74.3	70	116	103.7
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	74.3	70	116	103.7
Other comprehensive income (loss), net of tax	(16.5)	(9.8)	(19.7)	(11.7)
Total comprehensive income	57.8	60.2	96.3	92
Non-Guarantors
Income Statement [Abstract]
Net sales	275.6	289.2	507.9	558.7
Cost of products sold	162.4	171.4	305.1	346.2
Gross profit	113.2	117.8	202.8	212.5
Selling, general and administrative expense	34	31.9	69.1	68.5
Advertising and sales promotion expense	29.8	29	50.2	48.2
Research and development expense	0.2	0.4	0.5	0.8
Restructuring charges	3.3	1.1	7.5	14.9
Industrial sale charges		0		0
Interest expense associated with debt	0.2	1.8	0.9	3.3
Other income, net	(6.2)	(1.8)	(8.5)	(1.8)
Intercompany service fees	8.1	3.9	12.5	9.4
Equity in earnings of subsidiaries	0	0	0	0
Earnings before income taxes	43.8	51.5	70.6	69.2
Income tax (benefit) provision	7.7	10.4	13.2	13.6
Net earnings	36.1	41.1	57.4	55.6
Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract]
Net earnings	36.1	41.1	57.4	55.6
Other comprehensive income (loss), net of tax	6.7	7.3	(21.1)	(4.2)
Total comprehensive income	$ 42.8	$ 48.4	$ 36.3	$ 51.4

Guarantor and Non-Guarantor F58

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Balance Sheets) (Details) - USD ($) $ in Millions	Mar. 31, 2017		Sep. 30, 2016		Mar. 31, 2016	Sep. 30, 2015
Current assets
Cash and cash equivalents	$ 402.9		$ 738.9		$ 660.5	$ 712.1
Trade receivables, net	311		260.7
Inventories	366.4		309.2
Other current assets	142.8		143.2
Total current assets	1,223.1		1,452
Investment in subsidiaries	0		0
Intercompany receivables, net	0	[1]	0	[2]
Intercompany notes receivable	0	[1]	0	[2]
Property, plant and equipment, net	462		486.1
Goodwill	1,426.6		1,420.3
Other intangible assets, net	1,391.2		1,385.1
Other assets	27.7		28
Total assets	4,530.6		4,771.5
Liabilities [Abstract]
Current liabilities	557.4		868.2
Intercompany payables, net	0	[1]	0	[2]
Intercompany notes payable	0	[1]	0	[2]
Long-term debt	1,609.8		1,544.2
Deferred income tax liabilities	251.7		255.3
Other liabilities	262.2		274.8
Total liabilities	2,681.1		2,942.5
Shareholders' equity
Total shareholders' equity	1,849.5		1,829
Total liabilities and shareholders' equity	4,530.6		4,771.5
Eliminations
Current assets
Cash and cash equivalents	0		0		0	0
Trade receivables, net	0		0
Inventories	0		0
Other current assets	0		0
Total current assets	0		0
Investment in subsidiaries	(4,774.4)		(4,308.7)
Intercompany receivables, net	(616.3)	[1]	(541.1)	[2]
Intercompany notes receivable	(1.9)	[1]	(1.9)	[2]
Property, plant and equipment, net	0		0
Goodwill	0		0
Other intangible assets, net	0		0
Other assets	0		0
Total assets	(5,392.6)		(4,851.7)
Liabilities [Abstract]
Current liabilities	0		0
Intercompany payables, net	(616.3)	[1]	(541.1)	[2]
Intercompany notes payable	(1.9)	[1]	(1.9)	[2]
Long-term debt	0		0
Deferred income tax liabilities	0		0
Other liabilities	0		0
Total liabilities	(618.2)		(543)
Shareholders' equity
Total shareholders' equity	(4,774.4)		(4,308.7)
Total liabilities and shareholders' equity	(5,392.6)		(4,851.7)
Parent
Current assets
Cash and cash equivalents	0		0		0	0
Trade receivables, net	0		0
Inventories	0		0
Other current assets	0		0
Total current assets	0		0
Investment in subsidiaries	3,580		3,483.7
Intercompany receivables, net	0	[1]	0	[2]
Intercompany notes receivable	0	[1]	0	[2]
Property, plant and equipment, net	0		0
Goodwill	0		0
Other intangible assets, net	0		0
Other assets	1.9		2
Total assets	3,581.9		3,485.7
Liabilities [Abstract]
Current liabilities	20.9		21.4
Intercompany payables, net	616.3	[1]	541.1	[2]
Intercompany notes payable	0	[1]	0	[2]
Long-term debt	1,094.8		1,094.2
Deferred income tax liabilities	0		0
Other liabilities	0.4		0
Total liabilities	1,732.4		1,656.7
Shareholders' equity
Total shareholders' equity	1,849.5		1,829
Total liabilities and shareholders' equity	3,581.9		3,485.7
Guarantors
Current assets
Cash and cash equivalents	14.9		5.8		21.9	2.9
Trade receivables, net	164.9		108.9
Inventories	226.8		187.7
Other current assets	41.2		43.7
Total current assets	447.8		346.1
Investment in subsidiaries	1,194.4		825
Intercompany receivables, net	556.4	[1]	487.6	[2]
Intercompany notes receivable	1.9	[1]	1.9	[2]
Property, plant and equipment, net	332.6		343.8
Goodwill	1,061.8		1,061.9
Other intangible assets, net	1,227.9		1,235.1
Other assets	0.1		0.1
Total assets	4,822.9		4,301.5
Liabilities [Abstract]
Current liabilities	274		288.4
Intercompany payables, net	0	[1]	0	[2]
Intercompany notes payable	0	[1]	0	[2]
Long-term debt	515		450
Deferred income tax liabilities	227.6		232.4
Other liabilities	226.3		236.3
Total liabilities	1,242.9		1,207.1
Shareholders' equity
Total shareholders' equity	3,580		3,094.4
Total liabilities and shareholders' equity	4,822.9		4,301.5
Non-Guarantors
Current assets
Cash and cash equivalents	388		733.1		$ 638.6	$ 709.2
Trade receivables, net	146.1		151.8
Inventories	139.6		121.5
Other current assets	101.6		99.5
Total current assets	775.3		1,105.9
Investment in subsidiaries	0		0
Intercompany receivables, net	59.9	[1]	53.5	[2]
Intercompany notes receivable	0	[1]	0	[2]
Property, plant and equipment, net	129.4		142.3
Goodwill	364.8		358.4
Other intangible assets, net	163.3		150
Other assets	25.7		25.9
Total assets	1,518.4		1,836
Liabilities [Abstract]
Current liabilities	262.5		558.4
Intercompany payables, net	0	[1]	0	[2]
Intercompany notes payable	1.9	[1]	1.9	[2]
Long-term debt	0		0
Deferred income tax liabilities	24.1		22.9
Other liabilities	35.5		38.5
Total liabilities	324		621.7
Shareholders' equity
Total shareholders' equity	1,194.4		1,214.3
Total liabilities and shareholders' equity	$ 1,518.4		$ 1,836

[1]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.
[2]	Intercompany activities include product purchases between Guarantors and Non-Guarantors, charges for services provided by the Parent Company and various subsidiaries to other affiliates within the consolidated entity and other intercompany activities in the normal course of business.

Guarantor and Non-Guarantor F59

Guarantor and Non-Guarantor Financial Information (Schedule of Condensed Consolidating Statements of Cash Flows) (Details) - USD ($) $ in Millions	6 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash Flow from Operating Activities
Net cash flow from (used by) operations	$ (0.4)	$ (72.6)
Cash Flow from Investing Activities
Capital expenditures	(30.4)	(34.5)
Acquisitions, net of cash acquired	(34)	0
Proceeds from sale of assets	5.9	0
Payment for equity contributions		0
Net cash used by investing activities	(58.5)	(34.5)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	181	395.3
Cash payments on debt with original maturities greater than 90 days	(393)	(261)
Net increase (decrease) in debt with original maturities of 90 days or less	1.2	(5.6)
Common shares purchased	(58.5)	(78.9)
Intercompany dividend	0
Other, net	2	0
Proceeds for equity contributions		0
Net cash (used by) from financing activities	(267.3)	49.8
Effect of exchange rate changes on cash	(9.8)	5.7
Net increase (decrease) in cash and cash equivalents	(336)	(51.6)
Cash and cash equivalents, beginning of period	738.9	712.1
Cash and cash equivalents, end of period	402.9	660.5
Parent
Cash Flow from Operating Activities
Net cash flow from (used by) operations	56.5	78.9
Cash Flow from Investing Activities
Capital expenditures	0	0
Acquisitions, net of cash acquired	0
Proceeds from sale of assets	0
Payment for equity contributions		0
Net cash used by investing activities	0	0
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Net increase (decrease) in debt with original maturities of 90 days or less	0	0
Common shares purchased	(58.5)	(78.9)
Intercompany dividend	0
Other, net	2
Proceeds for equity contributions		0
Net cash (used by) from financing activities	(56.5)	(78.9)
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	0	0
Guarantors
Cash Flow from Operating Activities
Net cash flow from (used by) operations	(36.5)	(74.5)
Cash Flow from Investing Activities
Capital expenditures	(25)	(30.7)
Acquisitions, net of cash acquired	0
Proceeds from sale of assets	5.9
Payment for equity contributions		(0.5)
Net cash used by investing activities	(19.1)	(31.2)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	181	391
Cash payments on debt with original maturities greater than 90 days	(116)	(261)
Net increase (decrease) in debt with original maturities of 90 days or less	(0.3)	(5.3)
Common shares purchased	0	0
Intercompany dividend	0
Other, net	0
Proceeds for equity contributions		0
Net cash (used by) from financing activities	64.7	124.7
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash and cash equivalents	9.1	19
Cash and cash equivalents, beginning of period	5.8	2.9
Cash and cash equivalents, end of period	14.9	21.9
Non-Guarantors
Cash Flow from Operating Activities
Net cash flow from (used by) operations	49.6	(77)
Cash Flow from Investing Activities
Capital expenditures	(5.4)	(3.8)
Acquisitions, net of cash acquired	(34)
Proceeds from sale of assets	0
Payment for equity contributions		0
Net cash used by investing activities	(39.4)	(3.8)
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	4.3
Cash payments on debt with original maturities greater than 90 days	(277)	0
Net increase (decrease) in debt with original maturities of 90 days or less	1.5	(0.3)
Common shares purchased	0	0
Intercompany dividend	(70)
Other, net	0
Proceeds for equity contributions		0.5
Net cash (used by) from financing activities	(345.5)	4.5
Effect of exchange rate changes on cash	(9.8)	5.7
Net increase (decrease) in cash and cash equivalents	(345.1)	(70.6)
Cash and cash equivalents, beginning of period	733.1	709.2
Cash and cash equivalents, end of period	388	638.6
Eliminations
Cash Flow from Operating Activities
Net cash flow from (used by) operations	(70)	0
Cash Flow from Investing Activities
Capital expenditures	0	0
Acquisitions, net of cash acquired	0
Proceeds from sale of assets	0
Payment for equity contributions		0.5
Net cash used by investing activities	0	0.5
Cash Flow from Financing Activities
Cash proceeds from debt with original maturities greater than 90 days	0	0
Cash payments on debt with original maturities greater than 90 days	0	0
Net increase (decrease) in debt with original maturities of 90 days or less	0	0
Common shares purchased	0	0
Intercompany dividend	70
Other, net	0
Proceeds for equity contributions		(0.5)
Net cash (used by) from financing activities	70	(0.5)
Effect of exchange rate changes on cash	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents, beginning of period	0	0
Cash and cash equivalents, end of period	$ 0	$ 0